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Appendix 1 Exposure and outcome variables for literature 
reviews 
The interventions/exposures include: 
 Diet 
 food groups (starch, F&V, pulses, nuts and oils, meat  poultry fish and eggs, milk and dairy 
products, sugary drinks, coffee, tea, alcoholic drinks) 
 dietary patterns 
 dietary constituents (carbohydrates, protein, fat, alcohol, vitamins, minerals, phytochemicals) 
 Biomarkers of dietary intake67 
 Energy Balance  
 Energy Intake 
 Energy Expenditure 
 Body Composition  
 BMI 
 Weight 
 Skinfold measurements 
 DXA, BIA, CT scan, ultrasound 
 Waist circumference and other body size measures 
 Waist to hip ratio 
 Physical Activity 
 Total physical activity 
 Type of activity 
 Frequency, duration and intensity 
The outcome variables included: 
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For the HRQoL review 
1. Overall health related QoL (HRQoL). While HRQoL does not have an agreed definition, it is used to describe an 
individual’s assessment of their own general well-being. Overall HRQoL generally tries to encapsulate many different 
domains of an individual’s well-being. Its assessment generally involves standardised, self-administered questionnaires.   
2. HRQoL domains. The conceptual model of QoL in cancer survivors designed by Ferrell and Grant has been adopted 
to measure specific HRQoL domains (Hewitt et al., 2006). 
i) Physical well-being and symptoms 
 Functional activities 
 Fatigue 
 Sleep and rest 
 Overall physical health 
 Fertility 
 Pain 
ii) Psychological well-being 
 Control 
 Anxiety 
 Depression 
 Enjoyment/Leisure 
 Fear of recurrence 
 Cognition/Attention 
 Distress of diagnosis and control of treatment 
iii) Social well-being 
 Family distress 
 Roles and relationships 
 Affection/Sexual function 
 Appearance 
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 Enjoyment 
 Isolation 
 Finances 
 Work 
iv) Spiritual well-being 
 Meaning of illness 
 Religiosity 
 Transcendence 
 Hope 
 Uncertainty 
 Inner strength 
For the survival review 
1. Overall survival 
2. Disease free survival 
3. Disease specific survival 
 
  
APPENDICES 
 
381 
Appendix 2 Search strategy 
#1 cancer OR oncology OR oncolog* OR neoplasms OR neoplas* OR carcinoma OR carcinom* OR tumor OR 
tumour OR tumor* OR tumour* OR cancer* OR malignan*  
 
#2 endometr* OR uter* OR womb 
 
#3 post-treatment OR surviv* OR post-surg* OR patient* 
 
#4 #1 AND #2 AND #3 
 
#5 exercise OR exercises OR exercis* OR Exercise, Physical OR Exercises, Physical OR Physical Exercise OR 
Physical Exercises OR Exercise, Isometric OR Exercises, Isometric OR Isometric Exercises OR Isometric Exercise OR 
Warm-Up Exercise OR Exercise, Warm-Up OR Exercises, Warm-Up OR Warm Up Exercise OR Warm-Up Exercises OR 
Exercise, Aerobic OR Aerobic Exercises OR Exercises, Aerobic OR Aerobic Exercise OR endurance OR exercise therapy 
OR Therapy, Exercise OR Exercise Therapies OR Physiotherapy (Techniques) OR Physiotherapies (Techniques) OR 
Physical Therapy Techniques OR Physical Therapy Technique OR exercise test OR exercise tests OR muscle stretching 
exercise OR muscle stretching exercises OR physical therapy OR physical therapies OR strengthen* OR stretch* OR 
physiotherapy[text] OR physiotherap*[text] OR stability training OR training* OR exercise movement technique OR 
exercise movement techniques OR Movement Techniques, Exercise OR exercise movement technic OR Exercise 
Movement Technics OR physical exercise OR gymnastics OR gymnastic OR gymnastic* OR swim* OR treadmill OR 
walk* OR run* OR aerobic OR aerobics OR aerobic* OR cycl* OR jog* OR Exertion OR training program OR physical 
education and training OR Physical Education, Training OR Physical Education OR ﬁtness OR cardio training OR weight 
lifting OR power training OR muscle training OR rowing OR sports OR jump* 
 
#6 nutrition* OR diet* OR dietary pattern OR dietary patterns OR diet composition OR nutrient* OR 
macronutrient* OR micronutrient* OR food* OR eat* OR vitamin* OR mineral* OR dietary protein OR dietary fat OR 
dietary carbohydrate OR calorie OR alcohol OR energy  
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#7 cereal OR grain OR wholegrain OR wholewheat OR bread OR sugar OR vegetable OR fruit OR pulses OR 
beans OR lentils OR chickpeas OR legumes OR nut OR peanut OR seeds OR oils OR meat OR beef OR pork OR lamb 
OR poultry OR chicken OR turkey OR duck OR egg OR fish OR shellfish OR seafood OR dairy OR milk OR tea OR 
coffee OR beverages 
 
#8 nutritional status OR nutritional assessment OR nutrition assessment OR weight OR obes* OR overweight OR 
weight status OR weight change OR weight loss OR weight gain OR malnutrition OR malnourish* OR sarcopenia OR 
sarcopenic OR body composition OR skinfold* OR bioelectrical impedance OR BIA OR DXA OR DEXA OR double 
labeled water OR calorimetry OR BMI OR body mass index OR anthropometry OR waist circumference OR nutrition 
biomarkers 
 
#9 #5 OR #6 OR #7 OR #8 
 
#10  quality of life OR Qol OR condition* OR physical ﬁtness OR health status OR health level OR well-being OR 
wellness OR fatigue OR lifestyle OR physical effort OR physical skill OR physical activity OR muscle strength OR muscular 
strength OR lung function OR pulmonary function OR vital capacity OR recovery of function OR functional ability 
physical endurance OR range of motion OR VO2 OR VO(2peak) OR ventilatory threshold OR heart rate OR endurance 
OR activity energy expenditure OR DEXA OR DXA OR activity participation OR mets score OR Wingate anaerobic test 
OR dynamometer OR Sit-to-Stand OR ten repetition maximum OR muscle power OR sit-and-reach OR surviv* OR 
remission OR treatment outcome OR adverse effects OR comorbidities OR lymphedema OR osteoporosis OR cystitis OR 
proctitis OR hot flashes OR anaemia OR diabetes OR hypertension OR osteoarthritis OR cardiovascular disease OR 
Physical well-being OR Functional activities OR Fatigue OR Overall physical health OR fertility OR pain OR psychological 
well-being OR anxiety OR depression OR recurrence fear OR distress OR Social well-being OR appearance OR body 
image OR spiritual well-being 
 
#11 #4 AND #9 AND #10 
 
#12 transgenic OR mice OR hamster OR rat OR dog OR cat OR in vitro 
 
#13 #11 NOT #12 
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Retrieves 4316 results on PubMed 
 
Conference proceedings reviewed from the British Gynaecological Cancer Society, the International Gynaecological Cancer 
Society, the American Society of Gynaecologic Oncology, the European Society of Medical Oncology, the National Cancer 
Research Institute, the European Society of Gynaecologic Oncology, the American Society of Clinical Oncology, the Cancer 
Survivorship Research Conference, the American Institute for Cancer Research Conference, the and World Cancer 
Congress. 
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Appendix 3 Data extraction form 
General information 
Researcher performing data extraction 
Date of data extraction 
Identification features of the study: 
 Record number (to uniquely identify study) 
 Author 
 Article title 
 Citation 
 Type of publication (e.g. journal article, conference abstract) 
 Country of origin 
 Source of funding 
Study characteristics 
Aim/objectives of the study 
Study design 
Study inclusion and exclusion criteria 
Recruitment procedures used (e.g. details of randomisation, blinding) 
Unit of allocation (e.g. participant, GP practice, etc.) 
Participant characteristics 
Characteristics of participants at the beginning of the study e.g. 
 Age 
 Ethnicity 
 Socio-economic status 
 Disease characteristics 
APPENDICES 
 
385 
 Co-morbidities 
Number of participants in each characteristic category for intervention and control group(s) or mean/median characteristic 
values (record whether it is the number eligible, enrolled, or randomised that is reported in the study) 
Intervention and setting 
Setting in which the intervention is delivered 
Description of the intervention(s) and control(s) (e.g. duration, care provider, how the intervention was developed, 
theoretical basis (where relevant))  
For each pre-specified nutritional factor and physical activity: 
 Whether reported 
 Definition used in study 
 Measurement tool or method used 
 Unit of measurement (if appropriate) 
 Length of follow-up, number and/or times of follow-up measurements) 
Description of co-interventions 
Outcome data/results 
Unit of assessment/analysis 
Statistical techniques used 
For each pre-specified outcome (HRQoL, HRQoL domain measures, or types of survival) 
 Whether reported 
 Definition used in study 
 Measurement tool or method used 
 Unit of measurement (if appropriate) 
 Length of follow-up, number and/or times of follow-up measurements 
For all intervention group(s) and control group(s): 
 Number of participants enrolled 
 Number of participants included in analysis 
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 Number of withdrawals, exclusions, lost to follow-up 
 Summary outcome data e.g. 
 Dichotomous: number of events, number of participants 
 Continuous: mean and standard deviation 
Type of analysis used in study (e.g. intention to treat, per protocol) 
Results of study analysis: e.g. 
 Dichotomous: odds ratio, risk ratio and confidence intervals, p-value 
 Continuous: mean difference, confidence intervals 
Adjustment factors in the analysis. If a series of models is presented (e.g. unadjusted, age-adjusted or multi-adjusted), the 
fully adjusted model will be extracted. If the fully adjusted model is not provided, the most adjusted model will be extracted. 
Additional outcomes 
Record details of any additional relevant outcomes reported 
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Appendix 4 Published paper in Nutrition Reviews 
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Appendix 5 Cross-sectional study questionnaire 
Section 1: What you eat and drink 
1. Over the past month, how many portions of fruit did you usually eat?  
Please include those eaten at meal times or as a snack. Examples of a serving are 1 apple or banana, a large slice of 
melon, 2 plums or satsumas, a small bowl of grapes, 2 tablespoons of tinned fruit or ½ tablespoon of dried fruit. 
<1 per week 1 per week 2-3 per week 4-6 per week 1 per day 2 per day ≥3 per day 
       
 
2. Over the past month, how many portions of vegetables did you usually eat? 
Please include those eaten at meal times or as a snack. Examples of a serving are 2 heaped tablespoons of broccoli or 
carrots, 3 tablespoons of sweetcorn or peas or a bowl of salad. Please do not include potatoes, sweet potatoes or 
plantains as a vegetable serving. 
<1 per week 1 per week 2-3 per week 4-6 per week 1 per day 2 per day ≥3 per day 
       
 
3. Is the amount of fruit and vegetables you eat now… 
More than before your cancer 
diagnosis 
About the same as before your cancer 
diagnosis 
Less than before your cancer 
diagnosis 
   
 
4. Over the past month, about how much milk did you yourself use in a day, for example, on cereal or in tea 
or coffee? 
 None < a quarter-pint 
About a 
quarter-pint 
About a half 
pint 
≥ 1 pint 
Whole or channel 
islands 
     
Semi skimmed      
Skimmed      
 
5. Over the past month, how often did you eat/drink the following? 
 
Never/ 
rarely 
Once a 
week 
2-3 times a 
week 
4-6 times a 
week 
Once a day 
Twice a 
day 
≥3 times a 
day 
Chocolate, 
sweets 
       
Biscuits, cakes, 
buns, pastries, 
ice cream 
       
Regular/non-
diet fizzy 
drinks (e.g. 
coke, 7up) 
       
Diet/reduced 
sugar/sugar 
free fizzy 
drinks (e.g. 
diet coke) 
       
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Fruit juice 
(100% juice, 
unsweetened) 
       
Other regular/ 
non-diet 
drinks (e.g. 
squash, fruit 
drinks) 
       
Milkshakes, 
hot chocolate 
       
Water        
 
6. Over the past month, about how many rounded teaspoons or margarine, butter, other spread or oil did you 
usually use in a day (e.g. on bread, sandwiches, toast, potatoes, vegetables and in cooking)? 
 None 1 2 3 4 5 6 7+ 
Butter, lard or 
margarine (Ghee, 
Sunflower spread, 
buttery spread) 
        
Low fat spread 
(e.g. Flora light, 
Diet Clover) 
        
Oil (sunflower, 
olive, palm, 
rapeseed) 
        
 
7. Over the past month, how many times a week did you eat a serving of the following foods? 
 
Less than 
once a week 
or never 
Once or 
twice a week 
3-5 times a 
week 
At least 6 
times a week 
Cheese (including cream cheese, NOT cottage)     
Beef burgers, chicken in breadcrumbs, pate or sausages     
Beef, pork, lamb  
For vegetarians: nuts 
    
Bacon, meat pies     
Chicken or turkey     
Fish (NOT fried)     
ANY fried food, fried fish, chips, cooked breakfast, 
samosas 
    
Cakes, pies, puddings, pastries     
Biscuits, chocolate, crisps     
Coconut milk/coconut cream     
 
Section 2: Your physical activity 
You will complete this section with the help of the researcher. 
 
1. Were you employed in the last seven days?  
No (Skip to Q4)  Yes 
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  
2. How many days of the last seven days did you work? ___________ days 
3. How many total hours did you work in the last seven days?  __________ hours last week 
4. What two days do you consider your weekend days?  _____________  _____________ 
 
  Days       
  
1 
______ 
2 
______ 
3 
______ 
4 
______ 
5 
______ 
6 
______ 
7 
______ 
M
O
R
N
IN
G
 
Moderate        
Hard        
Very hard        
A
F
T
E
R
N
O
O
N
 
Moderate        
Hard        
Very hard        
E
V
E
N
IN
G
 
Moderate        
Hard        
ery hard        
 
4a. Compared to your physical activity over the past three months, was last week's physical activity more, less 
or about the same? 
More More More 
   
 
Your physical activity preferences 
1. Would you be interested in an exercise program?  
Yes No Maybe 
   
 
2. Would you be able to participate in an exercise program? 
Yes No Maybe 
   
 
3. What types of exercise you mostly interested in? 
Walking Weight training Swimming Aerobics Yoga 
     
 
4. When would you have preferred to start an exercise program? 
Before treatment During treatment 
Immediately after 
treatment 
3-6 months after 
treatment 
At least 1 year after 
treatment 
     
 
5. Who would you prefer to exercise with? 
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Alone 
With other cancer 
survivors 
With friends With family No preference 
     
 
6. Where would you prefer to exercise?  
At home At a community fitness centre 
At a cancer fitness 
centre 
No preference 
    
 
7. What time of day would you prefer to exercise? 
Morning Afternoon Evening No preference 
    
 
8. What is your favourite exercise in the summer? 
Walking Gardening Swimming Golf Bicycling 
     
 
9. What is your favourite exercise in the winter? 
Walking Weight training Skiing Swimming Stationary bike 
     
 
10. What intensity would you prefer to exercise at? 
Light Moderate Vigorous No preference 
    
 
11. Same or different activities for each exercise session? 
Same activity Different activity 
  
 
12. Supervised or not supervised exercise sessions?  
Supervised Unsupervised 
  
 
13. Spontaneous/flexible or scheduled exercise sessions? 
Spontaneous/flexible Scheduled 
  
 
Section 3: Your overall health 
1. In summary of my current and recent weight 
I currently weigh about _____ pounds or ____ kg 
I am about  _____ feet or ____ cm 
One month ago I weighed about  ____ pounds or ____ kg 
Six months ago I weighed about ____ pounds or ____ kg 
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2. During the past two weeks my weight has: 
decreased not changed increased 
   
 
3. How would you describe your weight? 
Very Underweight Slightly Underweight 
About the 
right 
weight 
Slightly Overweight Very Overweight 
     
 
4. Are you trying to gain weight, lose weight or neither? 
Gain weight Lose weight Neither 
   
 
5. How often have you worried about your overall health in the past year? 
Not at all A little Somewhat Quite a bit All the time 
     
 
6. How much has worrying about your health led you to change the way you ate in the past year? 
Not at all A little Somewhat Quite a bit All the time 
     
 
7. How much has worrying about your health led to be more physically active in the past year? 
Not at all A little Somewhat Quite a bit All the time 
     
 
8. On average, how many hours of sleep do you usually get . . .  
a. On a typical weeknight (Sunday - Thursday)?.................(WRITE IN NUMBER) _______ hours/night  
b. On a typical weekend night (Friday or Saturday)?...........(WRITE IN NUMBER) _______ hours/night  
 
Please rate your confidence about being able to successfully resist your desire to eat in the following situations by circling 
the figure that is closest to your view. 
  Not confident Very confident 
1 
I can resist eating when I am anxious 
(nervous). 
0 1 2 3 4 5 6 7 8 9 
2 I can control my eating on the weekends. 0 1 2 3 4 5 6 7 8 9 
3 
I can resist eating even when I have to say no 
to others. 
0 1 2 3 4 5 6 7 8 9 
4 
I can resist eating when I feel physically run 
down. 
0 1 2 3 4 5 6 7 8 9 
5 I can resist eating when I am watching TV. 0 1 2 3 4 5 6 7 8 9 
6 
I can resist eating when I am depressed (or 
down). 
0 1 2 3 4 5 6 7 8 9 
APPENDICES 
 
402 
7 
I can resist eating when there are many 
different foods available. 
0 1 2 3 4 5 6 7 8 9 
8 
I can resist eating even when I feel it’s 
impolite to refuse a second helping. 
0 1 2 3 4 5 6 7 8 9 
9 I can resist eating when I have a headache. 0 1 2 3 4 5 6 7 8 9 
10 I can resist eating when I am reading. 0 1 2 3 4 5 6 7 8 9 
11 
I can resist eating when I am angry (or 
irritable). 
0 1 2 3 4 5 6 7 8 9 
12 I can resist eating even when I am at a party. 0 1 2 3 4 5 6 7 8 9 
13 
I can resist eating even when others are 
pressuring me to eat. 
0 1 2 3 4 5 6 7 8 9 
14 I can resist eating when I am in pain. 0 1 2 3 4 5 6 7 8 9 
15 I can resist eating just before going to bed. 0 1 2 3 4 5 6 7 8 9 
16 
I can resist eating when I have experienced 
failure. 
0 1 2 3 4 5 6 7 8 9 
17 
I can resist eating when high-calorie foods are 
available. 
0 1 2 3 4 5 6 7 8 9 
18 
I can resist eating even when I think others 
will be upset if I don’t eat. 
0 1 2 3 4 5 6 7 8 9 
19 I can resist eating when I feel uncomfortable. 0 1 2 3 4 5 6 7 8 9 
20 I can resist eating when I am happy. 0 1 2 3 4 5 6 7 8 9 
 
 
Strongly 
disagree 
Disagree 
Partly 
disagree 
Not 
Sure 
Partly 
agree 
Agree 
Strongly 
agree 
If I never change my diet habits, I 
would feel very vulnerable to 
getting womb cancer again 
       
If I never change my diet habits, I 
would feel very vulnerable to 
getting another type of cancer 
       
If I never change my physical 
activity habits, I would feel very 
vulnerable to getting womb 
cancer again 
       
If I never change my physical 
activity habits, I would feel very 
vulnerable to getting another 
type of cancer 
       
 
 
Much 
below 
average 
Below 
average 
Average 
A little 
above 
average 
Much 
above 
average 
Compared to an average person of my sex and 
age, my chances of getting womb cancer are... 
     
Compared to an average person of my sex and 
age, my chances of getting any other cancer are... 
     
 
 Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
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There is not much I can do to improve my well-
being / quality of life 
     
 
If it would make me feel less tired I would be 
willing to…  
Strongly 
disagree 
Disagree Not sure Agree 
Strongly 
agree 
Lose weight      
Exercise more      
Eat more healthily      
 
If it would improve my quality of life I would be 
willing to…  
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
Lose weight      
Exercise more      
Eat more healthily      
 
Are there any reasons you wouldn’t want to do the following, or wouldn’t be able to do the following?   
(Please write them in the box next to each item)         
Lose weight 
 
Exercise More 
 
Eat more healthily 
 
 
Sometimes people have ideas about what prevents their cancer from coming back. Please rate how important each of the 
following factors is in preventing your cancer from recurring. Please use the blank boxes to put down any factors not already 
listed that you think could prevent your cancer from coming back 
 Not at all 
important 
Somewhat 
important 
Moderately 
important 
Important 
Very 
important 
Luck/chance      
Positive attitude      
Eating healthily      
Medical check-ups and screening      
Being physically active      
God’s will      
Healthy weight      
Smoking      
Other:_______________      
Other:_______________      
Other:_______________      
 
 Almost 
zero 
Very 
small 
Small 
Moder
ate 
Large 
Very 
large 
Almo
st 
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certai
n 
If I never change my diet habits, I think my 
chances of getting womb cancer again would 
be… 
       
If I never change my diet habits, I think my 
chances of getting any other cancer again would 
be… 
       
If I never change my physical activity habits, I 
think my chances of getting womb cancer again 
would be… 
       
If I never change my physical activity habits, I 
think my chances of getting any other cancer 
again would be… 
       
 
How often in the last 30 days has your family or friends done 
the following? 
Never Rarely 
A few 
times 
Often 
Vey 
Often 
Does 
not 
apply 
Encouraged you to do physical activity.       
Discussed how not doing physical activity is unhealthy.       
Reminded you to do physical activity.       
Shared ideas on how to get enough physical activity.       
Done physical activity with you.       
 
How many family members and close friends can you count on for help and support with your physical activity? 
None 1 – 2 3 – 4 5 – 6 7 or more 
 
How often in the last 30 days has your 
family or friends done the following? 
Never Rarely 
A few 
times 
Often Vey Often 
Does not 
apply 
Encouraged you to eat healthy foods.       
Discussed the benefits of healthy eating.       
Reminded you to choose healthy foods.       
Shared ideas on healthy eating.       
Eaten healthy meals with you.       
Complained about eating healthy food.       
 
How many family members and close friends can you count on for help and support with eating healthy foods? 
None 1 – 2 3 – 4 5 – 6 7 or more 
     
 
Please answer the following section by ticking one box for each statement to show which best describes your current 
lifestyle and behaviours. 
 
Strongly 
Disagree 
Disagree Not sure Agree 
Strongly 
Agree 
I have a regular pattern of eating (i.e. roughly eating at 
the same times each day). 
     
I have a good balance of different types of food in my 
diet (i.e. lots of starchy foods and fruit and vegetables, 
     
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and only tiny amounts of fatty/sugary foods and 
drinks). 
I can set effective eating and activity goals and work 
towards them. 
     
I am in control of my food portion sizes.      
I know what appropriate food portion sizes are for 
maintaining a healthy weight. 
     
I am able to manage triggers that lead to unhealthy 
behaviours (may include things like your mood, or the 
sight/smell of tempting food). 
     
I am confident that I understand the information on 
food labels. 
     
I feel in control of my eating habits.      
I feel confident and motivated to make any lifestyle 
changes. 
     
I am happy with my current weight.      
 
Section 4: Your quality of life 
 Not at all A little Quite a bit 
Very 
much 
 Do you have any trouble doing strenuous activities, like carrying a 
heavy shopping bag or a suitcase?  
    
Do you have any trouble taking a long walk?      
Do you have any trouble taking a short walk outside of the house?      
Do you need to stay in bed or a chair during the day?      
Do you need help with eating, dressing, washing yourself or using the 
toilet?  
    
During the past week:     
Were you limited in doing either your work or other daily activities?      
Were you limited in pursuing your hobbies or other leisure time 
activities?  
    
Were you short of breath?      
Have you had pain?      
Did you need to rest?      
Have you had trouble sleeping?      
Have you felt weak?      
Have you lacked appetite?      
Have you felt nauseated?      
Have you vomited?      
Have you been constipated?      
Have you had diarrhoea?      
Were you tired?      
Did pain interfere with your daily activities?      
Have you had difficulty in concentrating on things, like reading a 
newspaper or watching television?  
    
 Did you feel tense?      
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 Did you worry?     
 Did you feel irritable?      
 Did you feel depressed?      
 Have you had difficulty remembering things?      
 Has your physical condition or medical treatment interfered with 
your family life?  
    
 Has your physical condition or medical treatment interfered with 
your social activities?  
    
 Has your physical condition or medical treatment caused you 
financial difficulties?  
    
 
For the following questions please circle the number between 1 and 7 that best applies to you: 
How would you rate your overall health during the past week? 
1 2 3 4 5 6 7 
Very poor      Excellent 
How would you rate your overall quality of life during the past week? 
1 2 3 4 5 6 7 
Very poor      Excellent 
 
During the past week: 
 Not at all A little Quite a bit 
Very 
much 
Have you had swelling in one or both legs?      
Have you felt heaviness in one or both legs?     
Have you had pain in your lower back and / or pelvis?      
When you felt the urge to pass urine, did you have to hurry to get to 
the toilet?  
    
Have you passed urine frequently?     
 Have you had leaking of urine?     
 Have you had pain or a burning feeling when passing urine?     
 When you felt the urge to move your bowels, did you have to hurry 
to get to the toilet?  
    
 Have you had any leakage of stools?      
Have you been troubled by passing wind?      
Have you had cramps in your abdomen?      
Have you had a bloated feeling in your abdomen?      
Have you had tingling or numbness in your hands or feet?      
Have you had aches or pains in your muscles or joints?      
Have you lost hair?      
Has food and drink tasted differently from usual?      
Have you felt physically less attractive as a result of your disease or 
treatment?  
    
Have you felt less feminine as a result of your disease or treatment?      
     
APPENDICES 
 
407 
During the past 4 weeks:     
To what extent were you interested in sex?      
To what extent were you sexually active?     
     
Answer these questions only if you have been sexually active during the past 4 weeks:  
 Has your vagina felt dry during sexual activity?      
 Has your vagina felt short and / or tight?      
 Have you had pain during sexual intercourse or other sexual 
activity?  
    
 Was sexual activity enjoyable for you?     
 
Section 5: About you 
I am __ __ years old 
 
Which of these best describes your ethnic group? 
White Mixed Asian or Asian British Black or Black British Chinese/other 
 White British  
White and 
Black 
Caribbean 
 Indian  
Black 
Caribbean 
 Chinese  
 White Irish  
White and 
Black African 
 Pakistani  Black African  Other……… 
 
Any other 
White 
background 
 
White and 
Asian 
 Bangladeshi  
Any other 
Black 
background 
  
   
Any other 
Mixed 
background 
 
Any other Asian 
background 
    
 
Please tick the box which best describes your living arrangement: 
Own outright Own mortgage 
Rent from Local 
Authority/ 
Housing 
Association 
Rent privately Squatting 
Other 
(e.g. living with 
family/friends) 
      
      
What is your marital status? 
Single/ 
never married 
Married/ 
living with partner 
Married separated 
from spouse 
Divorced Widowed Civil partnership 
      
 
What is the highest level of education qualification you have obtained? 
 Degree or higher degree  O Level or GCSE equivalent (Grade A - C)  
 Higher education qualification below degree level  O Level or GCSE (Grade D - G) 
 A-levels or highers  No formal qualifications 
 ONC/BTEC  Other …………………………. 
 Still studying   
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7. Are you currently: 
 Employed full-time  Full-time homemaker 
 Employed part-time  Retired 
 Unemployed  Still studying 
 Self-employed  Disabled or too ill to work 
 
If you have anything else you would like to tell us about, please do so here 
 
  
Appendix 6 Demographic and lifestyle questionnaire for 
qualitative study 
1. What is your age?  
 
2. What is your gender? 
 Male  Female 
 
3. Which of these best describes your ethnic group? 
White Mixed Asian or Asian British Black or Black British Chinese/other 
 
White 
British 
 
White and Black 
Caribbean 
 Indian  Black Caribbean  Chinese  
 
White 
Irish 
 
White and Black 
African 
 Pakistani  Black African  Other… 
 
Any 
other 
White 
backgro
und 
 White and Asian  Bangladeshi  
Any other Black 
background 
  
   
Any other Mixed 
background 
 
Any other Asian 
background 
    
 
4. What is your marital status? 
Single/ 
never married 
Married/ 
living with 
partner 
Married 
separated from 
spouse 
Divorced Widowed Civil partnership 
      
 
5. Please tick the box which best describes your living arrangement: 
Own outright Own mortgage 
Rent from Local 
Authority/ 
Housing 
Association 
Rent privately Squatting 
Other 
(e.g. living with 
family/friends) 
      
 
6. Are you currently: 
 Employed full-time  Full-time homemaker 
 Employed part-time  Retired 
 Unemployed  Still studying 
 Self-employed  Disabled or too ill to work 
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7. What is the highest level of education qualification you have obtained? 
 Degree or higher degree  
O Level or GCSE 
equivalent (Grade A - C)  
 
Higher education qualification 
below degree level 
 
O Level or GCSE (Grade 
D - G) 
 A-levels or highers  No formal qualifications 
 ONC/BTEC  
Other 
…………………………. 
 Still studying   
 
Your Lifestyle 
8. What is your height? 
 cm OR ft in 
 
9. What is your weight? 
 kg OR st lbs 
 
10. At the present time are you: 
 Trying to lose weight 
 Trying to gain weight 
 Trying to maintain weight 
 None of the above 
 
11. In the past week, how often have you done 30 minutes or more of physical activity per day that was enough to raise 
your heart rate?  
This may include any moderate or vigorous activity such as sport, brisk walking, dancing or cycling for recreation or to 
get to and from places. It includes any activity that raises your heart rate moderately or intensively, and that accelerates 
your breathing 
Never 1 – 2 days 3 – 4 days 5 – 6 days Every day 
     
 
12. Over the past month, how often did you eat or drink the following? 
 <1 per 
week 
1   per 
week 
2 – 3 
per 
week 
4 – 6 
per 
week 
1       
per day 
2  
per day 
≥3  
per day 
Foods high in fats (e.g. butter, cheese, 
cream, chocolate, biscuits, cakes or 
pastries) 
       
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Foods with added sugars (e.g. sugary 
cereals, sweets, jam, puddings or fruit in 
syrup) 
       
Sugary and/or fizzy drinks (e.g. squash, 
cola) 
       
Red meat (e.g. beef, pork, lamb)        
Processed meat (including smoked, 
cured or salty such as ham, bacon) 
       
Poultry and fish not fried (e.g. chicken, 
turkey) 
       
Salty foods (foods high in salt/ sodium 
such as crisps, salted nuts) 
       
Dietary supplements (pills, capsules or 
liquids containing vitamins, minerals 
and/or herbs that are used to 
supplement or add to the diet) 
       
 
13. Over the past month, how many portions of fruit did you usually eat? 
Please include those eaten at meal times or as a snack. Examples of a serving are 1 apple or banana, a large slice of melon, 2 plums or satsumas, 
a small bowl of grapes, 2 tablespoons of tinned fruit or ½ tablespoon of dried fruit. 
<1 per week 1 per week 2-3 per week 4-6 per week 1 per day 2 per day ≥3 per day 
       
 
14. Over the past month, how many portions of vegetables did you usually eat? 
Please include those eaten at meal times or as a snack. Examples of a serving are 2 heaped tablespoons of broccoli or carrots, 
3 tablespoons of sweetcorn or peas or a bowl of salad. Please do not include potatoes, sweet potatoes or plantains as a 
vegetable serving. 
<1 per week 1 per week 2-3 per week 4-6 per week 1 per day 2 per day ≥3 per day 
       
 
15. Over the past month, how many portions of wholegrain foods did you usually eat? 
Please include those eaten at meal times or as a snack. Examples of a serving are 3-4 tablespoons of cereals; 2-3 heaped 
tablespoons of cooked brown rice or pasta; 1 medium slice of brown bread.  
<1 per week 1 per week 2-3 per week 4-6 per week 1 per day 2 per day ≥3 per day 
       
 
16. Over the past month, how many portions of non-wholegrain foods did you usually eat? 
Please include those eaten at meal times or as a snack.  Examples of a serving are 2-3 heaped tablespoons of cooked white 
rice or pasta; 1 medium slice of white bread.  
<1 per week 1 per week 2-3 per week 4-6 per week 1 per day 2 per day ≥3 per day 
       
 
17. Over the past month, how many portions of pulses did you usually eat? 
Please include those eaten at meal times or as a snack. Examples of a serving are 3 heaped tablespoons of pulses, e.g. 
chickpeas, baked beans or lentils. 
<1 per week 1 per week 2-3 per week 4-6 per week 1 per day 2 per day ≥3 per day 
       
 
18.  How often do you have a drink containing alcohol? 
(examples of a drink: half a pint or normal strength of beer, lager or cider; one 25ml measure of spirits such as vodka or 
whisky; one small 125ml glass of wine) 
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<1 per week 1 per week 2-3 per week 4-6 per week 1 per day 2 per day ≥3 per day 
       
 
19. Do you smoke or chew tobacco? 
Yes  No  Used to  
   
20.If yes/used to smoke, how many cigarettes per day do you smoke or used to smoke? 
10 or less  11 to 20  21 to 30  31 or more  
If yes/used to chew tobacco, please describe: 
What type: _____________________________________ 
Quantity per day: ________________________________ 
 
  
Appendix 7 Discussion protocol for focus groups and 
interviews 
 
Topics Discussion guide 
Background Information you want to share with the group, e.g. 
period since treatment, type of treatment 
Health Beliefs  
Beliefs about factors involved 
in causing cancer and keeping 
healthy in the future 
What to you is a healthy lifestyle? 
How important is healthy eating for someone that 
finished treatment? 
How important is physical activity for someone that 
finished treatment? 
Behaviour changes since 
recovering from cancer 
Have any of you made any other kind of changes post 
treatment in terms of trying to be healthier?  
What kind of barriers did you run into? 
What did you find helpful? 
Sources of information 
regarding long-term health  
How have you felt talking with friends, family about 
diet and physical activity after your treatment? 
Did any of you get any advice from a health 
professional about healthy eating and physical activity?  
Would any of you have liked more information about 
those? 
Program expectations How would you like to get that information if you 
were to have that conversation or you were to be 
given information? 
What would like to get from a healthy lifestyle 
program? 
How would you imagine that sort of information best 
being delivered? 
Program delivery When would you like to receive it?  
Engagement with the program We realize that it is hard to stay motivated to learn 
new information and strategies for healthy lifestyle, 
but what would keep you interested?  
Adherence barriers What would be the most important barriers for 
keeping you in the program? 
Summary and suggestions Further suggestions 
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Appendix 8 Coding tree 
1. Diet 
1.1. Behavior 
1.1.1. Past behavior 
1.1.2. Current behavior 
1.1.3. Changes in behavior 
1.2. Beliefs re cancer recurrence 
1.3. Beliefs re overall long-term health 
1.4. Barriers  
1.4.1. Practical 
1.4.2. Social 
1.4.3. Emotional 
1.4.4. Disease / Treatment effects 
1.5. Facilitators 
1.5.1. Practical 
1.5.2. Social 
1.5.3. Emotional 
1.5.4. Disease / Treatment 
2. Physical activity 
2.1. Behavior 
2.1.1. Past behavior 
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2.1.2. Current behavior 
2.1.3. Changes in behavior 
2.2. Beliefs re cancer recurrence 
2.3. Beliefs re overall long-term health 
2.4. Barriers 
2.4.1. Practical 
2.4.2. Social 
2.4.3. Emotional 
2.4.4. Disease / Treatment effects 
2.5. Facilitators  
2.5.1. Practical 
2.5.2. Social 
2.5.3. Emotional 
2.5.4. Disease / Treatment 
3. Energy balance and weight 
3.1. Beliefs re long-term health 
3.2. Beliefs re cancer 
4. Cancer 
4.1. Treatment effects 
4.2. Recurrence 
5. Advice and information 
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5.1. Advice received 
5.1.1. Timing 
5.1.2. Mode of delivery 
5.1.3. Source 
5.2. Information sought 
5.2.1. Trustworthiness 
5.3. Ideal advice 
5.3.1. Timing 
5.3.2. Mode of delivery 
5.3.3. Source 
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Appendix 9 COREQ Checklist 
 Guide questions/description Section of the 
paper where 
reported 
Domain 1: Research team and reﬂexivity 
Personal 
Characteristics 
  
Interviewer/facil
itator  
Which author/s conducted the interview or 
focus group? 
Procedure in 
methodology 
Credentials What were the researcher’s credentials? E.g. PhD 
MD 
Authors’ 
information 
Occupation  What was their occupation at the time of the 
study? 
Authors’ 
information 
Gender  Was the researcher male or female? Indirectly, see 
names 
Experience and 
training 
What experience or training did the researcher 
have? Relationship with participants 
Authors’ 
information 
Relationship 
established 
Was a relationship established prior to study 
commencement? 
Participants 
and recruitment 
in methodology 
Participant 
knowledge of 
the interviewer 
What did the participants know about the 
researcher? e.g. personal goals, reasons for doing 
the research 
N/A  
Interviewer 
characteristics 
What characteristics were reported about the 
interviewer/facilitator? e.g. Bias, assumptions, 
reasons and  interests in the research topic 
Authors’ 
information 
Domain 2: study design 
Theoretical 
framework 
  
Methodological 
orientation and 
Theory 
What methodological orientation was stated to 
underpin the study? e.g. grounded theory, 
discourse analysis,  ethnography,  
phenomenology, content analysis 
Analysis in 
methodology 
Participant 
selection 
  
Sampling How were participants selected? e.g. purposive, 
convenience, consecutive,  snowball 
Participants 
and recruitment 
in methodology 
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 Guide questions/description Section of the 
paper where 
reported 
Method of 
approach 
How were participants approached? e.g. face-to-
face, telephone, mail, email 
Participants 
and recruitment 
in methodology 
Sample size  How many participants were in the study? Figure 1 
Non-
participation                      
How many people refused to participate or 
dropped out? Reasons? Setting 
Figure 1 
Setting of data 
collection 
Where was the data collected? e.g. home, clinic, 
workplace 
Procedure in 
methodology 
Presence of non-
participants 
Was anyone else present besides the participants 
and researchers? 
Procedure in 
methodology 
Description of 
sample  
What are the important characteristics of the 
sample? e.g. demographic data, date 
Tables 1 & 2 
Data collection   
Interview guide  Were questions, prompts, guides provided by the 
authors? Was it pilot tested? 
Procedure in 
methodology 
Repeat 
interviews 
Were repeat interviews carried out? If yes, how 
many? 
N/A – No 
repeat 
interviews 
Audio/visual 
recording 
Did the research use audio or visual recording to 
collect the data? 
Procedure in 
methodology 
Field notes Were ﬁeld notes made during and/or after the 
interview or focus group? 
Procedure in 
methodology 
Duration                                     What was the duration of the interviews or focus 
group? 
Procedure in 
methodology 
Data saturation  Was data saturation discussed? Participants 
and recruitment 
in methodology 
& Discussion 
Transcripts 
returned  
Were transcripts returned to participants for 
comment and/or correction? 
N/A – It was 
not part of the 
protocol 
Domain 3: analysis and ﬁndings 
Data analysis   
Number of data 
coders 
How many data coders coded the data? Analysis in 
methodology 
Description of 
the coding tree 
Did authors provide a description of the coding 
tree? 
Additional file 
1 
Derivation of 
themes 
Were themes identiﬁed in advance or derived 
from the data? 
Analysis in 
methodology 
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 Guide questions/description Section of the 
paper where 
reported 
Software What software, if applicable, was used to manage 
the data? 
Analysis in 
methodology 
Participant 
checking 
Did participants provide feedback on the 
ﬁndings? 
N/A – It was 
not part of the 
protocol 
Reporting   
Quotations 
presented 
Were participant quotations presented to 
illustrate the themes / ﬁndings? Was each 
quotation identiﬁed? e.g. participant  number 
Results 
Data and 
ﬁndings 
consistent 
Was there consistency between the data 
presented and the ﬁndings? 
Results 
Clarity of major 
themes 
Were major themes clearly presented in the 
ﬁndings? 
Results 
Clarity of minor 
themes 
Is there a description of diverse cases or 
discussion of minor themes? 
Results 
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Appendix 10 Published paper in European Journal of Cancer 
Care 
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 422 
 
 423 
 
 424 
 
 425 
 
 426 
 
 427 
 
 428 
 
 429 
 
 
 430 
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Appendix 11 Examination of good fit between EBIs and 
needs assessment  
Evidence-based interventions (EBIs) identified in the NCI RTIPs database 
Search Criteria Used: Adults (40-65 years), Diet/Nutrition, Obesity, Older Adults (65+ 
years), Physical Activity, Survivorship/Supportive Care 
Evidence-based interventions (EBIs) identified in the Centre TRT database 
Search Criteria Used:  Individual/interpersonal, Health care,  Community,  Healthy Eating,  
Physical Activity,  Research-tested 
 
The description of the programs is directly reproduced by the aforementioned databases. 
Only programs targeting both healthy eating and physical activity were considered for review. 
    
NCI Program Title & Description (7 
out of the 45 programs listed) 
Programs identified in the Centre TRT 
database (3 out of 3 programs listed) 
Program 
Focus 
Population 
Focus 
Reason for 
exclusion 
22. Healthy Body Healthy Spirit  
Community-based program designed 
to promote healthy dietary habits and 
increase physical activity. (2005)  
Criteria Matched: Adults (40-65 years), 
Diet/Nutrition, Older Adults (65+ 
years), Physical Activity 
Behaviour 
Modification 
Faith-based 
Groups 
Faith-based 
program 
renders the 
adaptation 
difficult 
24. Keep It Off  
Designed to promote healthy dietary 
habits and increase physical activity to 
reduce obesity. (2013)  
Criteria Matched: Adults (40-65 years), 
Obesity, Older Adults (65+ years) 
Awareness 
building, 
Behaviour 
Modification 
and Self-
efficacy 
Adults Telephone 
based 
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NCI Program Title & Description (7 
out of the 45 programs listed) 
Programs identified in the Centre TRT 
database (3 out of 3 programs listed) 
Program 
Focus 
Population 
Focus 
Reason for 
exclusion 
29. Physical Activity and Nutrition for 
Health  
Designed to increase physical activity 
and promote healthy dietary habits. 
(2005)  
Criteria Matched: Adults (40-65 years), 
Diet/Nutrition, Older Adults (65+ 
years) 
Awareness 
building and 
Behaviour 
Modification 
School 
Children 
School-
based with 
insufficient 
evidence of 
effectivene
ss 
32. Promoting Healthy Living: 
Assessing More Effects (PHLAME)  
Designed to increase physical activity 
and promote healthy dietary habits to 
reduce obesity. (2007)  
Criteria Matched: Adults (40-65 years), 
Diet/Nutrition, Obesity, Physical 
Activity 
Behaviour 
Modification 
Employees Focus on 
workspace 
/ 
environme
ntal 
changes 
that may 
not be 
applicable 
35. Step Ahead Intervention School 
Worksite Weight Gain Prevention  
Designed to promote healthy dietary 
habits and physical activity to reduce 
obesity. (2014)  
Criteria Matched: Adults (40-65 years), 
Obesity, Older Adults (65+ years) 
Awareness 
building and 
Behaviour 
Modification 
Employees Focus on 
workspace 
/ 
environme
ntal 
changes 
that may 
not be 
applicable 
36. StrongWomen - Healthy Hearts  
Designed to promote healthy dietary 
habits and increase physical activity to 
reduce obesity. (2009)  
Criteria Matched: Adults (40-65 years), 
Diet/Nutrition, Obesity, Older Adults 
(65+ years), Physical Activity 
Awareness 
building and 
Behaviour 
Modification 
Overweight
/Obese 
Individuals 
No long-
term 
follow-up 
data  
38. The COACH approach  
Designed to promote healthy dietary 
habits and increase physical activity to 
reduce obesity. (2008)  
Criteria Matched: Adults (40-65 years), 
Obesity, Older Adults (65+ years) 
Awareness 
building, 
Behaviour 
Modification 
and Self-
efficacy 
Adults Very 
resource 
intensive, 
low impact 
score (for 
reach and 
effect size)  
A New Leaf...Choices for Healthy 
Living  
Behaviour 
Modification 
Adults Physical 
activity did 
not 
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NCI Program Title & Description (7 
out of the 45 programs listed) 
Programs identified in the Centre TRT 
database (3 out of 3 programs listed) 
Program 
Focus 
Population 
Focus 
Reason for 
exclusion 
This is a structured assessment and 
counselling tool that emphasizes 
practical strategies for making changes 
in dietary and physical activity 
behaviours. The New Leaf program 
can be used in the prevention and 
treatment of cardiovascular disease, 
diabetes, obesity, and other chronic 
diseases. 
and Self-
efficacy 
improve 
when 
objectively 
measured 
Baltimore Healthy Stores (BHS)  
BHS uses a store’s existing facilities to 
improve access to healthy food and to 
increase consumers’ knowledge, self-
efficacy and behavioral intentions 
about healthy food choices and food 
preparation through health education 
and point-of-purchase marketing 
strategies. 
Knowledge 
and self-
efficacy 
Adults Only about 
diet / 
introduces 
changes in 
the 
environme
nt that may 
not be 
applicable 
Weight-Wise  
Behavioural weight management 
program designed to help women lose 
weight. 
Behaviour 
Modification  
Women No long-
term 
follow-up 
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Appendix 12 Material & individual responses for “Shape-
Up” telephone interviews  
Interview guide about the “Shape-Up” program (Adapted from (Krueger, 1997)) 
1. How did you find the focus group discussion? (Only to focus group participants) 
2. What one thing do you like the best? 
3. What one thing do you like the least? 
4. If you could change one thing about the materials, what would it be? 
5. What would get you to participate in the program? 
6. Suppose that you were trying to encourage a friend to participate in this program. 
What would you say? 
7. Within the adapted booklet, advice will be added specifically for endometrial 
cancer survivors. What are your views on: 
a) Tailoring the information to endometrial cancer survivors 
b) Guidelines on managing GI symptoms (e.g. nausea, vomiting, diarrhoea)  
c) Adding cooking classes to the program (to improve cooking skills) 
d) Q&As re misconceptions and myths for nutrition and cancer (e.g. antioxidant 
supplements reduce recurrence)  
8. Who would you like to facilitate the group meetings? 
9. Would you prefer it as a group program or as a self-help? 
10. Do you have any other advice for us as we introduce this new program? 
 
Coding framework for the Shape-Up feedback interviews 
Code lists 
Content 
Cooking classes 
Facilitator 
Format 
Mode of delivery 
 
  
 435 
Individual suggestions & comments to manual’s content, and format and relevant 
adaptations of the manual 
Content-specific suggestions / comments Relevant adaptations 
More detailed monitoring of physical activity classes (e.g. 
if something did not work well and why) 
Participants can add this in 
the empty space of the 
diaries 
Inclusion of exercises for lymphoedema Specific exercises for 
lymphoedema were not 
added given the lack of 
evidence and the complexity 
of lymphoedema. However, 
the positive association 
between lymphoedema and 
physical activity was 
mentioned. Specific safety 
instructions were given. 
Acknowledgement of the individual variability of 
treatment-related symptoms 
Both topics are covered in 
the adapted booklet 
Acknowledgement of the meaning of risk factors 
Less emphasis on food labelling These will be addressed (see 
next section) 
Physical activity expectations and how to safely increase it 
Inclusion of memorable messages 
Elimination of emphasis on overweight and obesity and 
of the BMI chart 
More emphasis on the importance of whole grains 
Inclusion of a food diary to assess triggers of bowel 
symptoms 
A column will be included 
in the diaries to report 
potential bowel symptoms 
Inclusion for information about soya products Specific information will be 
included 
 
Suggestion of using a high powered blender to make 
drinks with fruits and vegetables, which may eliminate 
fibre-related bowel symptoms 
This suggestion will be 
added as a tip in the manual 
Acknowledgement of the importance of overall well-
being and of spending time doing things they enjoy 
As this is the main aim of 
the intervention, this issue 
has been particularly 
stressed in the manual but 
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Content-specific suggestions / comments Relevant adaptations 
only in terms of diet and 
activity. 
Inclusion of information about food intolerances and 
allergies 
These issues will be further 
discussed with the research 
team. 
Inclusion of information about effective management of 
radiotherapy bowel symptoms and fatigue 
Reference to relevant 
sources were added in the 
resources section (e.g. Pelvic 
Radiation Association) 
Format-specific suggestions / comments Relevant adaptations 
Darker (black) font to facilitate reading Font colour will be black 
Photographic presentation of portion sizes Reference to posters from 
the WCRF regarding 
portion sizes will be added 
in the resources 
A poster with portion sizes for the kitchen 
Inclusion of a one-page summary These will be further 
discussed among the 
researchers, given their cost 
implications. 
Reducing the size of the manual by half 
Dividing the manual into smaller books 
Inclusion of an index  
Clearer separation of the sections 
To be formatted as a Filofax to facilitate insertion and 
removal of diaries 
Decreasing the quality of the paper to reduce the weight 
of the booklet 
Darker (black) font to facilitate reading Font colour will be black 
The self-monitoring forms were many and too 
complicated 
No change because forms 
will be given in different 
formats 
It might work along with a mobile application Reference to mobile 
applications about 
monitoring diet and physical 
activity was added at the 
resources section 
 
  
Appendix 13 Differences in matrices between original and 
adapted “Shape-Up”  
The following matrices highlight the differences in change objectives, theory, and 
practical applications between the two versions of the “Shape-Up” program. The first 
matrix is referring to establishing a healthy diet and the second to increasing physical 
activity. The nested tables refer to the behaviour change techniques (BCTs) in bold 
text, their link with the theory in brackets, and their practical application in non-bold 
text. The practical applications with no fill are present only in the booklet; those with 
light blue are present both in the booklet and the sessions; and those with dark blue 
only in sessions. The text highlighted in green and red refers to aspects of the program 
that were added and removed, respectively during the adaptation process. Therefore, 
those in red colour existed in the original “Shape-Up” but were removed in the adapted 
version. Abbreviations: SCT: Social Cognitive Theory, CT: Control Theory. 
 
  
HEALTHY DIET: MATRIX FOR CHANGE OBJECTIVES 
 Behaviour: establish a healthy diet 
Performance 
objectives 
Behavioural determinants 
Outcome expectations (physical, 
social, self-evaluative) 
Knowledge Self-efficacy Goals 
PO 1. Have a regular 
eating pattern 
OE 1.1. Identify their current eating 
pattern 
Feedback on behaviour (CT) 
From a list of 7 different eating 
patterns, the person picks the 
one that applies to them and 
reads feedback based on their 
choices  
 
 
 
KN 1.1. Recognise the benefits of 
regular eating and breakfast 
Information about health 
consequences (SCT) 
Verbal and written explanation 
that regular eating can regulate 
hunger and that breakfast can 
improve cardiometabolic risk  
 
SE 1.1. Express confidence in their 
ability to start following a 
regular eating pattern and 
eating breakfast regularly 
Habit formation (SCT) 
Be prompted to start eating at the 
same time each day  
 
SE 1.2. Express confidence in eating 
regularly 
Problem solving and social 
support (unspecified) (SCT) 
Identify barriers to eating 
regularly during the previous 
week 
Generate strategies (as a group) 
to overcome barriers and increase 
facilitators to regular eating  
 
GO 1.1. Be prompted to increase 
the difficulty of their goals 
slowly until behaviour is 
performed 
Graded tasks (SCT) 
Be prompted to make 
behavioural changes in the 
following order 
 Changes towards PO 1 
 Changes towards PO 2 
 Changes towards PO 3  
 
GO 1.2. Set a regular eating goal 
Behavioural goal setting (SCT) 
Set a SMART regular eating goal 
based on GO 4.1. 
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PO 2. Adhere to the 
“Eatwell plate” 
principles 
OE 2.1. Recognise the value of the 
behavioural 
recommendations  
Framing / reframing (CT) 
Identify the difference between a 
fad diet and learning how to carry 
on with the healthy lifestyle for a 
lifetime  
 
OE 2.2. Review their shopping 
pattern 
Feedback on behaviour (CT) 
From a list of 7 different 
shopping patterns, the person 
picks the one that applies to 
them and reads feedback based 
on their choices  
 
OE 2.3. Be aware that others also 
face difficulties following a healthy 
diet after cancer treatment and 
increase motivation to be more 
active 
Information about others’ 
approval (SCT) 
Read motivational quotes from 
other cancer survivors about 
healthy eating  
 
KN 2.1. Understand components of 
each food group and their 
benefits and risks 
Information about health 
consequences (SCT) 
Explanation of the health 
benefits (vegetables, fruits, whole 
grains, pulses, healthy oils) and 
risks of the various food groups 
(foods/drinks high in fat/sugar, 
saturated and trans fats, refined 
grains, red meat, excessive 
alcohol intake)  
Recognise the principles of 
Eatwell plate, the five food 
groups and their ideal 
proportions  
Recognise the different names of 
sugar and fat on food labels  
Understand the risks and benefits 
of supplements  
 
KN 2.2. Understand the causes, and 
consequences of obesity 
Information about health 
consequences  
Recognise the various factors 
that influence weight and the 
health consequences of obesity 
SE 2.1. Express confidence in 
choosing healthy foods and 
drinks 
Instructions on how to 
perform the behaviour (SCT) 
Recognise ways of eating enough 
fruits, vegetables and whole 
grains; making healthy choices 
from the protein & dairy groups; 
eating less fatty and sugary foods; 
and cutting down alcohol 
Differentiate refined and 
unrefined carbohydrates (also 
low/high GI) 
Recognise ways of cutting down 
on sugary drinks 
Recognise ways of having 
healthier lunches 
Recognise which snack to choose 
Identify foods to store in the 
cupboard / fridge / freezer 
List ways that eating out can fit 
into the new eating plan 
Recognise healthy and unhealthy 
options in various types of 
restaurants 
Recognise healthy options in 
ready meals 
GO 2.1. Set a healthy eating goal 
Behavioural goal setting (SCT) 
Set one or more SMART goal on 
eating a balanced diet based on 
GO 4.1. 
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OE 2.3. Increase expectation that 
health care professionals will 
approve their lifestyle changes 
Credible source (SCT) 
Read information from nurses in 
favour of healthy eating  
 
 
 
 
 
 
 
 
 
Recognise ways of having an 
affordable healthy diet 
Consult when necessary 
suggested cookbooks 
 
Behavioural practice / 
rehearsal (SCT) 
Practice matching various foods 
under each food group 
 
SE 2.2. Express confidence in 
maintaining a balanced diet 
in the presence of bowel 
symptoms 
Instructions on how to 
perform the behaviour (SCT) 
Recognise ways of maintaining a 
balanced diet in the presence of 
bowel symptoms 
 
SE 2.3. Express confidence in food 
safety 
Instructions on how to 
perform the behaviour (SCT) 
Recognise ways of avoiding risk 
for food born-illnesses 
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SE 2.4. Express confidence in 
adhering to the eatwell 
plate when eating out 
Conserving mental resources 
(SCT) 
Be prompted to carry wallet-size 
cards with healthy and unhealthy 
options in various types of 
restaurants 
 
SE 2.5. Express confidence in 
understanding food labels 
Behavioural practice/rehearsal 
(SCT) 
Examine the ingredients list 
Compare nutritional values of 
various sweet and savoury snacks 
Compare different product labels 
to the guidelines and to the guide 
to good shopping 
Examine the sugar, fat, and 
calorie content per 100g, 
compare it to guidelines, and 
decide if the foods are healthy 
options 
Interpret nutritional claims 
correctly  
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Calculate % calories from fat in 
food and compare it with 
guidelines 
 
PO 3. Keep an eye on 
portion sizes 
OE 3.1. Recognise their aims 
regarding food quantity 
Information about health 
consequences (SCT) 
Written explanation that keeping 
an eye on portion sizes can help 
them avoid undesirable weight 
gain 
 
KN 3.1. Understand what are the 
recommended amounts 
from each food group to 
avoid weight gain 
Instructions on how to 
perform the behaviour (SCT) 
Describe what constitutes a 
serving from each group 
Describe the amounts of servings 
aiming for from each group 
Observe portion sizes of various 
foods from all food groups 
 
 SE 3.1. Express confidence in 
keeping an eye on portion 
sizes 
Behavioural practice/rehearsal 
(SCT) 
Using the food portions, create a 
day’s food intake aligned with the 
recommendations 
 
GO 3.1. See GO 4.1 
PO 4. Create and 
maintain a 
discrepancy-
reducing 
feedback loop  
OE 4.1. Express confidence in their 
ability to change their 
behaviour 
Pros and cons (SCT) 
Explain of the components of 
motivation to change 
KN 4.1. Become aware of their 
current dietary pattern 
Self-monitoring of behaviour 
(CT) 
Record the time, amount and 
type of food and drink each day 
using (if preferred) the Shape-Up 
diary 
 
SE 4.1. Express confidence in their 
ability to increase their 
willpower 
Verbal (and written) 
persuasion about capabilities 
(SCT) 
Understand that willpower is a 
practicable skill (written) 
GO 4.1. Compose an action plan 
towards establishing a 
healthy diet 
Action planning and goal 
setting (behaviour) 
Plan in detail the performance of 
their first SMART goal  
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Review examples of advantages 
and disadvantages for (not) 
changing their lifestyle 
Analyse their advantages and 
disadvantages of (not) changing 
their lifestyle 
 
OE. 4.2. Recognise the importance 
of making one behaviour 
change at a time 
Framing / reframing (CT) 
Recognise that making one 
behaviour change at a time will 
be more advantageous in the long 
term compared to making too 
many changes at once 
 
OE 4.3 Recognise the importance of 
realistic weight targets 
Framing / reframing 
Recognise the value of healthy 
range of weight rather than an 
ideal weight and the benefits of 
gradual weight loss 
 
OE 4.4. Recognise the value of self-
monitoring  
Understand that they can learn to 
swap unhealthy habits to healthy 
ones 
 
SE 4.2. Express confidence in 
setting SMART healthy 
eating goals 
Behavioural practice (SCT) 
Define the principles of SMART 
goal setting 
Practise translating vague goals to 
SMART ones 
 
SE 4.3. Express confidence in 
rewarding themselves for 
achieving their SMART 
goals 
Self-incentive & non-specific 
incentive (SCT) 
List their own potential rewards  
 
SE 4.5. Decide if discrepancies exist 
when comparing intake to 
personal goals and 
guidelines 
Discrepancy between current 
behaviour and goal (CT) 
Plan things that might get in the 
way of achieving the goal 
Plan how and when they will 
review the goal 
Plan who might help them 
 
GO 4.2. Set a lifestyle target 
Goal setting (outcome) (SCT) 
Set a lifestyle goal (e.g. healthier life) as an 
outcome of changing eating and activity 
behaviours 
 
GO 4.3. Set a realistic weight goal 
Goal setting (outcome) 
Set a realistic weight goal (either 
loss or maintenance) as an 
outcome of changed eating and 
physical activity patterns 
 
GO 4.4. Compare intake to personal 
goals and guidelines 
Self-monitoring of behaviour 
and goal setting (behaviour) 
(CT) 
Categorise consumed foods and 
drinks in servings from each food 
group 
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Self-monitoring of behaviour 
(CT) 
Written explanation that self-
monitoring of behaviour can 
improve behaviour practice and 
maintenance 
Provision of food diaries each 
week 
Record the time, amount and 
type of food and drink each day 
using (if preferred) the Shape-Up 
diary 
Verbal re-affirmation that self-
monitoring of behaviour through 
diaries can improve behaviour 
practice and maintenance at the 
end of the programme 
Self-monitoring of outcome of 
behaviour 
Receive advice to weight 
themselves on a regular basis that 
they will decide upon 
Record weight in their diaries 
 
OE 4.5. Express confidence in (not) 
seeking social support 
Problem solving and social 
support (unspecified) (SCT) 
Compare their score (SE 5.2) to 
personal goals or guidelines in 
order to draw attention to the 
discrepancy. 
 
SE 4.6 Maintain self-monitoring 
through diaries 
Problem solving (SCT) 
Identify as a group barriers to 
keeping a food and activity diary  
Discuss ways in which they can 
overcome the barriers 
 
SE 4.7. Express confidence in 
achieving SMART goals 
Review of behavioural goals, 
problem solving, and social 
support (unspecified) (SCT) 
Re-examine their behaviours. 
Facilitator and group members 
provide evaluative feedback if 
they have (not) met the SMART 
criteria and if they have rewarded 
themselves for achieving the goal. 
Participants should problem-
solve themselves with the help of 
the rest of the group ways of 
making their goals fit with the 
SMART criteria  
 
Score their daily consumption of 
each food group 
Review their SMART goal 
Evaluate outcome of their 
SMART goal 
 
GO 4.5. Expressing confidence in 
maintaining monitoring, 
goal setting, incentivisation 
after the end of the 
programme 
Action planning, goal setting 
(behaviour), problem solving, 
and self-incentive (SCT) 
Plan in detail their dietary and 
physical activity SMART goals, 
identify barriers and facilitators 
and strategies to 
facilitate/overcome them, specify 
review date, and reward  
Review behaviour goals and 
information about others’ 
approval (SCT) 
As a group, review each 
participant’s goals and discuss 
other’s views on the plan and 
potential modifications if goals 
unrealistic or participants 
overwhelmed 
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Identify helpful and unhelpful 
social support towards healthy 
eating changes (e.g. family, 
friends, health care professionals) 
Problem solve potential social 
impediments 
 
OE 4.6. Plan their self-reward 
Self-incentive & non-specific 
incentive (SCT) 
Understand the value of rewards 
for achieving their SMART goals 
Brainstorm ideas for non-food 
incentives 
Plan to reward self when they 
review their goals if they achieve 
their SMART goals 
 
OE 4.7 Reward success  
Social reward (SCT) 
Facilitator verbally praises 
participants if and only if 
participants have progressed with 
their goals  
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OE 4.8. Receive support from each 
other while making 
behavioural changes  
Social support (unspecified) 
(SCT) 
Distribute to each other their 
contact details so that they 
support each other on the 
behavioural changes during the 
program 
Be aware that others also face 
difficulties following a healthy 
lifestyle after cancer treatment  
Get support and ideas from 
group members on following a 
healthy lifestyle  
 
OE 4.9. Asses their own BMI and 
compare it against standard 
cut-offs 
Feedback on outcomes of 
behaviour 
Demonstrate BMI calculation 
Apply the BMI to their own 
weight and height and compare it 
with standard cut-offs 
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OE 4.10. Identify potential sources 
of external support at the 
end of the programme 
Social support (unspecified) 
(SCT) 
Discuss if continuous support 
from other healthy lifestyle 
services can be helpful after the 
end of the programme  
Advice on how they can find 
information about support in 
their local area  
 
PO 5. Deal effectively 
with triggers of 
unhealthy 
eating and 
lapses 
OE 5.1. Reframe unhelpful thoughts 
about lapses to helpful 
ones 
Framing/reframing (CT) 
Identify five helpful and four 
unhelpful example thoughts 
about lapses from their healthy 
eating and physical activity plan 
For the unhelpful thoughts, 
generate alternatives that are 
more positive and/or would help 
them recover from the lapse 
 
 SE 5.1. Express confidence in 
dealing with external 
triggers 
Avoidance/reducing exposure 
to cues for the behaviour (CT) 
Be prompted to identify and try 
to avoid cues promoting 
unhealthy eating (e.g. sight or 
smell of food)  
Distraction (CT) 
Be prompted to use an 
alternative focus for attention to 
avoid triggers for comfort eating  
Problem solving (SCT) 
Be prompted to identify the 
triggers for unhealthy eating and 
generate a strategy to overcome 
GO 5.1. See GO 4.1 
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them (e.g. do not skip meals 
before going to a party to avoid 
overeating) 
Analyse various example external 
triggers (e.g. buffet party) and 
select strategies (i.e. avoidance, 
distraction, problem solving) to 
overcome them 
Satiation  
Receive advice to repeatedly 
expose themselves to snack 
foods without eating them in 
order to reduce the person’s 
appetite for them. 
 
SE 5.2. Express confidence in 
dealing with cravings 
Problem solving & distraction 
(SCT) 
Identify example eating situations 
either as hunger or craving  
Receive advice to eat regularly to 
deal with hunger and information 
that cravings last for only 20 
minutes 
Generate strategies to overcome 
cravings (e.g. distraction) 
Be prompted to distract self 
when a craving comes 
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SE 5.3. Express confidence in 
dealing with unhelpful 
thoughts 
Problem solving (SCT) 
Understand how unhelpful 
thoughts trigger unhealthy 
behaviours 
Identify unhelpful thoughts that 
trigger unhealthy eating 
behaviours 
Generate and select strategies to 
overcome unhelpful thoughts 
Behavioural practice (SCT) 
Practice translating unhelpful 
thoughts that might impede 
healthy eating goals to helpful 
ones 
Self-talk (SCT) 
When experiencing an unhelpful 
thought, be prompted to remind 
themselves what they are trying 
to achieve and why  
 
SE 5.5. Express confidence in 
dealing with emotions 
Problem solving (SCT) 
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Understand how emotions can 
trigger unhealthy behaviours 
Identify emotions that trigger 
unhealthy eating behaviours 
Generate and select strategies to 
overcome them  
Distraction (CT) 
Identify ways for distracting from 
the mood 
Be prompted to focus attention 
on this alternative way when in 
the mood 
Behavioural substitution (CT) 
Be prompted to substitute screen 
time with other neutral or 
positive behaviours 
Reduce negative emotions 
(SCT) 
Be prompted to ask themselves 
whether eating will change the 
problem/emotion they currently 
facing 
 
SE 5.6. Express confidence in 
dealing with lapses 
Verbal persuasion about 
capability (SCT) 
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Facilitator to mention that lapses 
are a normal part of the process 
of change and that they can still 
make healthier choices as long as 
they learn how to deal with the 
lapses  
Information about antecedents 
(SCT) 
Identify the lapse example (eating 
biscuits) among the factors 
(social and environmental events, 
emotions, and cognitions) that 
lead to the lapse and its 
consequences 
Put a chain of antecedents 
(events, emotions, cognitions), 
lapse (unhealthy eating, social 
event), and consequences in the 
right order.  
Problem solving (SCT) 
Analyse the above factors, lapse, 
and consequences, and generate 
strategies to overcome them 
Verbal persuasion about 
capability (SCT) 
Facilitator to reaffirm that 
participants can successfully 
overcome future lapses by 
reflecting on previous ones 
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Reduce negative emotions 
(SCT) 
Distinguish a behavioural lapse 
from a relapse 
Receive advice on the use of a 5-
step cognitive strategy to reduce 
negative emotions in order to 
deal successfully with a lapse. 
 
  
PHYSICAL ACTIVITY: MATRIX FOR CHANGE OBJECTIVES 
 Behaviour: increase physical activity to the extent of at least meeting the PA guidelines  
Performance objectives Behavioural determinants 
Outcome expectations (physical, 
social, self-evaluative) 
Knowledge Self-efficacy Goals 
PO 1.  Reduce sedentary 
behaviours 
OE 1.1. Assess their current PA 
and evaluate required PA 
changes 
Feedback on behaviour (CT) 
Complete a quiz about physical 
activity levels and receive written 
feedback based on their score. 
 
OE 1.2. Understand the difference 
between physical activity 
and exercise 
Framing/reframing (CT) 
Understand that exercise is only 
one of a range of physical 
activities that can promote health 
 
KN 1.1. Recognise the benefits of 
PA 
Information about health and 
emotional consequences 
(SCT) 
Know about the physical and 
emotional benefits of physical 
activity 
Know about the link between 
physical activity and sleep 
Recognise the connection 
between weight control and PA 
Recognise approximate energy 
expenditure (kcal) for various 
lifestyle activities 
 
 
SE 1.1. Express confidence in 
being more physically 
active 
Problem solving (SCT) 
Identify potential barriers to 
physical activity and generate 
strategies to overcome them  
 
SE 1.2. Express confidence in 
reducing sedentary 
behaviours 
Instructions on how to 
perform the behaviour (SCT) 
Recognise ways of reducing 
sedentary behaviours 
Recognise ways of improving 
sleep quality 
 
GO 1.1 Set a goal to reduce 
sedentary time 
Behavioural goal setting (SCT) 
Set a SMART physical activity 
goal based on GO 4.1. 
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PO 2.  Increase lifestyle 
activities 
OE 2.1. Express confidence in 
(not) seeking social 
support 
Problem solving and social 
support (unspecified) (SCT) 
Identify helpful and unhelpful 
social support towards PA 
changes (e.g. family, friends, 
health care professionals) 
Problem solve potential social 
impediments 
 
OE 2.2 Be aware that others also 
face difficulties being 
physically active after 
cancer treatment and 
increase motivation to be 
more active 
Information about others’ 
approval (SCT) 
Read motivational quotes from 
other cancer survivors about 
physical activity  
 
OE 2.3. Increase expectation that 
health care professionals 
will approve their lifestyle 
changes 
Credible source (SCT) 
Read information from nurses in 
favour of physical activity 
 
KN 2.1. Describe the PA 
recommendations 
Instructions on how to 
perform the behaviour (SCT) 
Know the PA recommendations 
 
 
SE 2.1. Express confidence in 
increasing lifestyle 
activities 
Instructions on how to 
perform the behaviour (SCT) 
Recognise ways of increasing 
lifestyle activities 
 
GO 2.1. Set a physical activity goal  
Behavioural goal setting (SCT) 
Set a SMART physical activity 
goal based on GO 4.1. 
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PO 3.  Increase organised 
activities  
 KN 3.1. Recognise safety issues 
while physically active 
Instructions on how to 
perform the behaviour (SCT) 
Recognise when and how to start 
and stop exercising 
 
SE 3.1. Express confidence in 
doing more strength, 
balance, and flexibility 
exercises 
Demonstration of the 
behaviour & instructions on 
how to perform the behaviour 
(SCT) 
Provide pictures of cancer 
survivors demonstrating sample 
strength, balance, and flexibility 
exercises and instructions of how 
to perform those 
Behavioural practice/rehearsal 
(SCT) 
Practice some of the resistance 
exercises during the session 
following the booklet’s 
instructions  
 
GO 3.1. Plan in detail their 
organised PA 
Problem solving and action 
planning (SCT) 
Recognise ways of organised PA 
Identify what activities they could 
do 
Examine where and when they 
will do the activity 
Examine where and when they 
will do the activity 
Examine if they need to involve 
others 
Question if they will keep it up 
Examine if they need to travel 
Examine if it is safe to exercise 
 
GO 3.2. Set a goal to increase 
organised activities 
Behavioural goal setting (SCT) 
Set a SMART physical activity 
goal based on GO 4.1. 
 
PO 4.  Create and 
maintain a 
discrepancy-
reducing feedback 
loop 
OE 4.1. Express confidence in their 
ability to change their 
behaviour 
Pros and cons (SCT) 
Explain of the components of 
motivation to change 
 SE 4.1. Express confidence in their 
ability to increase their 
willpower 
Verbal and written persuasion 
about capabilities (SCT) 
GO 4.1. Compose an action plan 
towards increasing PA 
Action planning and goal 
setting (behaviour) (SCT) 
Plan in detail the performance of 
their first SMART goal  
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Review examples of advantages 
and disadvantages for (not) 
changing their lifestyle 
Analyse their advantages and 
disadvantages of (not) changing 
their lifestyle 
 
OE. 4.2. Recognise the importance 
of making one behaviour 
change at a time 
Framing / reframing (CT) 
Recognise that making one 
behaviour change at a time will 
be more advantageous in the long 
term compared to making too 
many changes at once 
 
OE 4.3. Recognise the value of 
self-monitoring and 
become aware of their PA 
pattern 
Self-monitoring of behaviour 
(CT) 
Verbal and written explanation 
that self-monitoring of behaviour 
can improve behaviour practice 
and maintenance 
Be prompted to use a pedometer 
Provision of activity diaries 
Understand that willpower is a 
practicable skill (written) 
Understand that they can learn to 
swap unhealthy habits to healthy 
ones 
 
SE 4.2. Express confidence in 
setting SMART healthy 
eating goals 
Behavioural practice (SCT) 
Define the principles of SMART 
goal setting 
Practise translating vague goals to 
SMART ones 
 
SE 4.3. Express confidence in 
rewarding themselves for 
achieving their SMART 
goals 
Self-incentive & non-specific 
incentive (SCT) 
List their own potential rewards  
 
SE 4.4. Decide if discrepancies exist 
when comparing PA to 
personal goals and 
guidelines 
Discrepancy between current 
behaviour and goal (CT) 
Compare their pedometer count 
and moderate PA (SE 5.2) to 
Plan things that might get in the 
way of achieving the goal 
Plan how and when they will 
review the goal 
Plan who might help them 
 
GO 4.4. Compare PA to personal 
goals and guidelines 
Self-monitoring on behaviour 
and goal setting (behaviour) 
(CT) 
Review their SMART goal 
Evaluate outcome of their 
SMART goal 
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Record the amount and type of 
moderate PA each day using (if 
preferred) the Shape-Up diary 
Record pedometer count 
 
OE 4.5. Express confidence in 
(not) seeking social 
support 
Problem solving and social 
support (unspecified) (SCT) 
Identify helpful and unhelpful 
social support towards PA 
changes (e.g. family, friends, 
health care professionals) 
Problem solve potential social 
impediments 
 
OE 4.6. Plan their self-reward 
Self-incentive & non-specific 
incentive (SCT) 
Understand the value of rewards 
for achieving their SMART goals 
Brainstorm ideas for non-food 
incentives 
Plan to reward self when they 
review their goals if they achieve 
their SMART goals 
 
OE 4.7 Reward success  
Social reward (SCT) 
personal goals or guidelines in 
order to draw attention to the 
discrepancy. 
 
SE 4.5 Maintain self-monitoring 
through diaries 
Problem solving (SCT) 
Identify as a group barriers to 
keeping a food and activity diary  
Discuss ways in which they can 
overcome the barriers 
 
SE 4.6. Express confidence in 
achieving SMART goals 
Review of behavioural goals, 
problem solving, and social 
support (unspecified) (SCT) 
Re-examine their behaviours. 
Facilitator and group members 
provide evaluative feedback if 
they have (not) met the SMART 
criteria and if they have rewarded 
themselves for achieving the goal. 
Participants should problem-
solve themselves with the help of 
the rest of the group ways of 
making their goals fit with the 
SMART criteria  
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Facilitator verbally praises 
participants if and only if 
participants have progressed with 
their goals  
 
OE 4.8. Receive support from each 
other while making 
behavioural changes  
Social support (unspecified) 
(SCT) 
Distribute to each other their 
contact details so that they 
support each other on the 
behavioural changes during the 
program 
Be aware that others also face 
difficulties following a healthy 
lifestyle after cancer treatment  
Get support and ideas from 
group members on following a 
healthy lifestyle  
 
OE 4.9. Identify potential sources 
of external support at the 
end of the programme 
Social support (unspecified) 
(SCT) 
Discuss if continuous support 
from other healthy lifestyle 
services can be helpful after the 
end of the programme  
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Advice on how they can find 
information about support in 
their local area  
 
 
PO 5. Deal effectively 
with triggers of 
sedentary 
behaviours and 
lapses 
  SE 5.1. Express confidence in 
dealing with external 
triggers 
Avoidance/reducing exposure 
to cues for the behaviour (CT) 
Be prompted to identify and try 
to avoid cues promoting PA (e.g. 
watching a boxset)  
Distraction (CT) 
Be prompted to use an 
alternative focus for attention to 
avoid triggers for screen time 
Problem solving (SCT) 
Be prompted to identify the 
triggers for sedentary behaviours 
and generate a strategy to 
overcome them (e.g. have an 
alternative PA plan in case of 
foul weather) 
 
SE 5.4. Express confidence in 
dealing with fatigue 
Problem solving (SCT)  
Understand what fatigue is  
GO 5.1. See GO 4.1 
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Select strategies from a list of 
suggestions to help them 
overcome fatigue and facilitate 
physical activity  
 
 
SE 5.4. Express confidence in 
dealing with unhelpful 
thoughts 
Behavioural practice (SCT) 
Practice translating unhelpful 
thoughts that might impede 
healthy eating goals to helpful 
ones 
Self-talk (SCT) 
When experiencing an unhelpful 
thought, be prompted to remind 
themselves what they are trying 
to achieve and why  
 
SE 5.5. Express confidence in 
dealing with emotions 
Distraction (CT) 
Identify ways for distracting from 
the mood 
Be prompted to focus attention 
on this alternative way when in 
the mood 
Behavioural substitution (CT) 
Be prompted to substitute screen 
time with other neutral or 
positive behaviours 
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Reduce negative emotions 
(SCT) 
Be prompted to ask themselves 
whether not being active will 
change the problem/emotion 
they currently facing 
 
SE 5.6. Express confidence in 
dealing with lapses 
Reduce negative emotions 
(SCT) 
 
Distinguish a behavioural lapse 
from a relapse 
Distinguish a lapse from a relapse 
Receive advice on the use of a 5-
step cognitive strategy to reduce 
negative emotions in order to 
deal successfully with a lapse. 
 
Information about antecedents 
(SCT) 
 
Put a chain of antecedents 
(events, emotions, cognitions), 
lapse (sedentary behaviour), and 
consequences in the right order.  
 
Problem solving (SCT)  
Analyse the above factors, lapse, 
and consequences, and generate 
strategies to overcome them 
 
Verbal persuasion about 
capability (SCT) 
 
Facilitator to reaffirm that 
participants can successfully 
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overcome future lapses by 
reflecting on previous ones 
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Appendix 14 Supplementary protocol information 
for the DEUS pilot study 
 
Funding  
Completion of this project was funded by the UCL Grand Challenges Scheme, 
the St. Bartholomew’s Hospital Nurses League, the Department of Women’s 
Cancer at The UCL EGA Institute for Women’s Health, and NIHR University 
College London Hospitals Biomedical Research Centre, London, UK. The 
funders had no role in the study design; collection, management, analysis, and 
interpretation of data; writing of the report; and the decision to submit the study 
for publication.  
Data Management 
This study was registered for Data Protection at UCL Records Office. The 
Reference Number is: Z6364106/2014/12/14. All participating researchers and 
NHS staff who were involved in the study acted to preserve patient 
confidentiality according to the Data Protection Act 1998 and the NHS Code of 
Confidentiality. All computers used to collect or store data were password 
protected. All original data were stored in compliance with the Data Protection 
Act. 
DEUS pilot study 
Diet & Exercise in Uterine Cancer Survivors 
Figure: Study logo 
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All paper and voice records were transferred to a university computer at UCL 
and encrypted after being checked for any inconsistencies. The data entry 
screens resembled the completed paper forms. The option to select a value from 
a list of valid codes and a description of each code were available where 
appropriate. Two MSc students (Alia Sukkar, Maria Papadopoulou) entered the 
data under my guidance and supervision using a two-pass verification method, 
as there were some inconsistencies in the first entry of the data. Qualitative data 
were transcribed verbatim and checked against the recordings for accuracy. 
Other relevant files (e.g. addresses) were transferred to a university computer at 
UCL and encrypted. The encryption key (i.e. password) was kept separate to all 
other study material as described below. The code sheet linking the participant's 
name to their study ID was kept separate from all other study materials in i) a 
locked fire−proof filing cabinet in the Department of Women’s Cancer in areas 
with limited access and ii) a password protected electronic file on a UCL server. 
In accordance with published guidelines, patients' personal details (e.g. name, 
full address) was not recorded on any study data collection instruments. Each 
patient was allocated a numeric ID as they enter the study, and by which they 
were known throughout. This identifier was recorded on all study documents. 
All data were analysed in an anonymous format. All results were anonymous and 
reported in such a way that individuals were not identifiable. 
A scanned copy of the questionnaire for the last follow-up follows. 
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Monitoring 
Data monitoring 
Given the short length of the intervention, the low risk of harm (see below) and 
the short follow-up of the intervention, an external Data Monitoring Committee 
was not needed. Thus, an interim analysis was not performed. Nonetheless, the 
researchers recruiting, implementing, and assessing the intervention provided a 
report to the monthly meeting of the research team about study progress, 
including potential adverse effects, and missing data.  
The UCLH/UCL/Royal Free Joint Research Office, on behalf of UCL as 
Sponsor, monitors and conducts random audits on a selection of studies in its 
clinical research portfolio. Monitoring and auditing is conducted in accordance 
with the Department of Health Research Governance Framework for Health & 
Social Care (April, 2005), and in accordance with the Sponsor’s monitoring and 
audit policies and procedures. 
Harms 
The participants had undergone treatment for endometrial cancer that may 
include surgery, radiotherapy and chemotherapy. Consequently, they may feel 
unwell and/or fatigued due to their disease and/or treatment. Participation in 
each 60-minute assessment and in the 90-min sessions is not expected to 
increase risk or burden, however, as this may require some time and energy the 
interview was conducted in an environment easily accessed by the participants. 
Participants had the option to withdraw from the study at any time, without 
giving a reason and without affecting the quality of the care they receive. The 
researcher allowed breaks if needed. It was expected that removal of shoes for 
the body composition measurement could have been a minor burden. Some 
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people found talking about weight and their body composition measurements 
(e.g. fat content) embarrassing but the session was not anticipated to cause 
distress. However, the researcher approached these topics in a sensitive manner. 
Appointments and groups were organised at convenient times whenever 
possible.  
“Shape-Up following cancer treatment” was a very low intensity intervention 
that should be suitable for most people with health conditions, such as diabetes, 
heart failure, and high blood pressure. Observed changes were unlikely to be 
associated with unintended or adverse effects (NICE, 2014b). The proposed 
modifications to lifestyle i.e. dietary and physical activity changes were in 
accordance with published guidelines for cancer survivors (Rock et al., 2012). 
The lifestyle program generally recommended a diet high in fruits, vegetables, 
beans and whole grains; foods with high fibre content. It was anticipated that 
some participants would not be able to tolerate some of those foods due to their 
radiotherapy and chemotherapy bowel effects. As those foods differ among 
participants and across the cancer trajectory for each participant, alternative 
foods were recommended accordingly. Furthermore, participants completed a 
safety pre-activity questionnaire based on the “American College of Sports 
Medicine Roundtable on Exercise Guidelines for Cancer Survivors” before 
undertaking physical activity (Schmitz et al., 2010). If contra-indications arose, 
participants were advised to seek medical advice before engaging in higher levels 
of physical activity. 
It was not anticipated that the assessments, the intervention, or the interviews 
would cause any distress but if a participant became distressed during the study 
sessions, they could terminate the session whenever they wish. Should the 
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session cause discomfort to the participant, she had the right to take a break, ask 
questions and terminate her participation. In the unlikely event that the 
participant became distressed, the researcher followed guidelines provided, as 
follows: 
 Be empathetic, understanding, and non-judgmental in all patient 
interactions 
 If still distressed, offer to contact partner/carer/close other; 
 If requested, provide feedback (the content of which will be agreed with 
the respondent) to the health care professional that is primarily 
responsible for their care. 
All potential adverse effects and unintended effects of the intervention were 
reported, as they constitute one of the secondary outcome measures.  
Ethics and dissemination 
Research ethics approval 
The study protocol and documents were reviewed and approved by the relevant 
sponsor and NHS REC (15/LO/0154) with respect to scientific content and 
compliance with applicable research and human subjects regulations. A copy of 
the approval letter follows. 
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Protocol amendments 
Potential protocol modifications were formally approved by the REC before 
being implemented. The amendments seen below were communicated to the 
trial registries and outlined at the dissemination of the trial.  
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Consent 
If a patient were interested to hear about the study, the clinician introduced her 
to the researcher. In a separate research room, the researcher provided the 
relevant details to the potential participant. Following adequate time to consider 
participation and resolve queries, those wishing to participate signed provided 
signed informed consent. All participants had to consent for themselves. A copy 
of the latest patient information sheet and consent form follows. 
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Confidentiality 
All data were handled according to the Data Protection Act 1998 and the NHS 
Code of Confidentiality as described in section 7.1.2. Identifiable data will be 
securely kept for 12 months after the end of the trial. 
Declaration of interests 
None declared. 
Access to data 
Only the investigators had access to personal identifiable data. These data were 
not disclosed to any other person. Individuals from University College London, 
from regulatory authorities or from the NHS Trust may have looked at non-
identifiable data, where relevant. 
Post-trial care 
Archiving 
 UCL and each participating site recognise that there is an obligation to archive 
study-related documents at the end of the study (as such end is defined within 
this protocol). The Chief Investigator confirms that she will archive the study 
master file at UCLH/ for the period stipulated in the protocol and in line with 
all relevant legal and statutory requirements. The Principal Investigator at each 
participating site agrees to archive his/her respective site’s study documents for 
twenty years and in line with all relevant legal and statutory requirements. 
 Insurance 
University College London held insurance against claims from participants for 
harm caused by their participation in this clinical study. No such issue arose in 
the study.  
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Intellectual Property Rights 
 All background intellectual property rights (including licences) and know-how 
used in connection with the study shall remain the property of the party 
introducing the same and the exercise of such rights for purposes of the study 
shall not infringe any third party’s rights. 
All intellectual property rights and know-how in the protocol and in the results 
arising directly from the study, but excluding all improvements thereto or clinical 
procedures developed or used by each participating site, shall belong to UCL. 
Each participating site agrees that by giving approval to conduct the study at its 
respective site, it is also agreeing to effectively assign all such intellectual property 
rights (“IPR”) to UCL and to disclose all such know-how to UCL. Each 
participating site agrees to, at the request and expense of UCL, execute all such 
documents and do all acts necessary to fully vest the IPR in UCL.  
Nothing in this section shall be construed so as to prevent or hinder the 
participating site from using know-how gained during the performance of the 
study in the furtherance of its normal activities of providing or commissioning 
clinical services, teaching and research to the extent that such use does not result 
in the disclosure or misuse of confidential information or the infringement of 
an intellectual property right of UCL. This does not permit the disclosure of any 
of the results of the study, all of which remain confidential. 
Dissemination policy 
The period between the closeout of the study and the release of the study results 
would be kept to the minimum possible. An interval of three to four months 
was expected to be needed before submitting results to relevant journals. Before 
submission, the research team would review the papers accordingly. The primary 
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papers of the study would report the primary outcome measures of the study. 
The results would be disseminated regardless of the magnitude or direction of 
effect. All investigators would be authors of future publications with authorship 
eligibility to follow international guidelines (International Committee of Medical 
Journal, 2003). The study results were also disseminated to the clinical teams in 
the participating centres, and the participants. 
A completely de-identified dataset will be disseminated to a relevant data archive 
for sharing purposes. The interval for this will be no later than three years after 
the closeout of the study. 
Roles and responsibilities 
Trial Management Group 
AL and MTK conceived the study. DAK, AL, RB and MTK initiated the study 
design and RM helped with protocol development and implementation. AL and 
MTK are the grant holders. MB provided statistical support and DAK 
conducted primary statistical analysis. All authors contributed to refinement of 
the study protocol and approved it. 
DAK was responsible for the day to day monitoring and management of the 
study reporting directly to AL. AL had overall responsibility for the project. The 
two CIs (AL, RM) oversaw the identification of potential participants in each 
site. RJB and TMK, provided expert advice during the study and with the 
analysis and interpretation of the results. RJB was responsible for intervention 
assignment, and auditing the study including review of the records for accuracy. 
Trial Steering Committee 
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An external Trial Steering Committee met twice during the study to oversee the 
trial. Prof. Allan Hackshaw, Deputy Director of Cancer Research UK & UCL 
Cancer Trials Centre chaired the Committee. The committee also included two 
other independent members (Dr Abigail Fisher, Dr Aleksandra Gentry-
Maharaj), the two CIs (AL, RM), the trial co-investigators, and a lay 
representative. 
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Appendix 15 Supplementary data analysis 
information for the DEUS pilot study 
Baseline characteristics of the whole sample (n=60) 
 
 
Shape-Up 
(n=29) 
Care as usual 
(n=31) 
Total 
Age, mean (SD) 62.2 (9.1) 61.1 (7.5) 61.6 (8.3) 
Race    
White 17 (65) 18 (67) 35 (66) 
Asian 4 (15) 6 (22) 10 (19) 
Black  3 (12) 1 (4) 4 (8) 
Mixed / Other 2 (8) 2 (7) 4 (8) 
Living arrangement    
Own outright 12 (46) 11 (41) 23 (43) 
Own mortgage 6 (23) 6 (22) 12 (23) 
Rent from local 
authority 
6 (23) 6 (22) 12 (23) 
Rent privately 2 (8) 4 (15) 6 (11) 
Marital status    
Married / living 
with partner 
13 (50) 17 (63) 30 (57) 
Married / separated 4 (15) 1 (4) 5 (9) 
Divorced 3 (11) 2 (7) 5 (9) 
Widowed 2 (8) 4 (15) 6 (11) 
Civil partnership - 1 (4) 1 (2) 
Single 4 (15) 2 (8) 6 (11) 
Education    
Degree or higher 
degree 
10 (39) 10 (37) 20 (38) 
Higher education 
below degree level 
2 (8) 3 (11) 5 (9) 
Secondary 
education 
11 (42) 12 (44) 23 (43) 
No formal 
qualifications 
3 (12) 2 (7) 5 (9) 
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Shape-Up 
(n=29) 
Care as usual 
(n=31) 
Total 
Employment    
Full time / self-
employed 
10 (39) 13 (48) 23 (43) 
Part time 3 (12) 1 (4) 4 (8) 
Retired 10 (39) 12 (44) 22 (42) 
Other 3 (!2) 1 (4) 4 (8) 
Smoking    
Current 2 (8) 2 (7) 4 (8) 
Former 4 (15) 5 (19) 9 (17) 
Weekly gross household 
income estimate (£), 
median (IQR)  
817 (186) 824 (161) 820 (172) 
IMD (quintile)    
1 – most deprived 1 (19) 4 (15) 9 (17) 
2 9 (35) 8 (30) 17 (32) 
3 4 (15) 8 (30) 3 (23) 
4 3 (12) 3 (11) 4 (11) 
5 – least deprived 5 (19) 4 (15) 5 (17) 
Time since diagnosis in 
years, mean (SD) 
1.0 (1.0) 1.4 (1.0) 1.2 (1.0) 
Time since diagnosis in 
months, mean (SD) 
18.6 (11.4) 21.4 (11.6) 20.1 (11.4) 
Time since completion 
of primary treatment in 
years, mean (SD) 
0.9 (0.9) 1.2 (1.0) 1.0 (0.9) 
Time since completion 
of primary treatment in 
months, mean (SD) 
16.5 (11.4) 18.9 (12.0) 17.7 (11.6) 
Chemotherapy 
treatment 
3 (12) 7 (26) 10 (19) 
External beam 
radiotherapy 
7 (27) 13 (48) 20 (38) 
Brachytherapy 12 (46) 14 (52) 26 (49) 
Cancer stage    
IA 12 (46) 16 (59) 28 (53) 
IB 11 (42) 6 (22) 17 (32) 
II 2 (8) 3 (11) 5 (9) 
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Shape-Up 
(n=29) 
Care as usual 
(n=31) 
Total 
IIIA 1 (4) 2 (7) 3 (6) 
Cancer grade    
1 6 (23) 8 (30) 14 (26) 
2 12 (50) 11 (41) 24 (45) 
3 7 (27) 8 (30) 15 (28) 
Histological type    
Type I 22 (85) 20 (74) 42 (79) 
Type II 4 (15) 7 (26) 11 (21) 
WHO performance 
status 
   
0 20 (77) 23 (85) 43 (81) 
1 6 (23) 3 (11) 9 (17) 
2 - 1 (4) 1 (2) 
Selected comorbidities    
Diabetes 3 (12) 4 (15) 7 (13) 
Hypertension 6 (23) 8 (30) 14 (26) 
Dyslipidaemia 3 (11) 3 (11) 6 (11) 
Asthma 2 (8) 4 (15) 6 (11) 
Osteoporosis 1 (4) 2 (7) 3 (6) 
Weight, mean (SD) 69.8 (14.5) 72.2 (14.5)  
BMI, mean (SD) 27.3 (6.4) 28.7 (5.8) 28.0 (6.1) 
BMI, median (IQR) 26.2 (7.2) 27.0 (7.5) 26.8 (6.5) 
% Fat, mean (SD) 35.3 (7.5) 37.3 (6.1) 36.3 (6.9) 
FMI, mean (SD) 10.0 (4.1) 11.0 (4.0) 10.5 (4.1) 
FFMI, mean (SD) 17.3 (2.5) 17.7 (2.1) 17.5 (2.3) 
Metabolic age, mean 
(SD) 
58.5 (14.2) 59.7 (12.7) 59.1 (13.3) 
Visceral fat rating, mean 
(SD) 
8.8 (3.3) 9.4 (3.1) 9.1 (3.2) 
Percentages might not add to 100 due to rounding. IMD: Index of multiple 
deprivation, IQR: Interquartile range. Body composition data for n=59 
One participant in the active intervention without stage and grade because she 
was diagnosed with endometrial hyperplasia. 
Data are presented as n (%) unless otherwise specified 
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Statistical considerations in the data analysis 
 Dietary data at 8-weeks 
An ANCOVA was run to determine the intervention effect on the AHEI score 
at 8-weeks. Visual inspection of a scatterplot confirmed that the linear 
relationship between 8-week AHEI scores and each of BMI, age, and baseline 
AHEI scores for each arm. The interaction terms were not statistically 
significant (all p>0.05) indicating homogeneity of regression slopes. Shapiro-
Wilk’s test indicated that standardised residuals at each arm were normally 
distributed (p>0.05). Homoscedasticity and homogeneity of variances were also 
confirmed by visual inspection of a scatterplot and Levene's test (p>0.05), 
respectively. No data outliers were found based on standardized residuals ≥ ±3 
SD’s. 
An ANCOVA was run to determine the intervention effect on the vegetable 
score at 8-weeks. Visual inspection of a scatterplot confirmed that the linear 
relationship between vegetable AHEI scores and each of BMI, age, and baseline 
vegetable scores for each arm. The interaction terms were not statistically 
significant (all p>0.05) indicating homogeneity of regression slopes. Shapiro-
Wilk’s test indicated that standardised residuals at the active intervention arm 
were normally distributed (p>0.05) but not on usual care arm (p=0.016). The 
analysis was carried on regardless because the residual were normally distributed 
based on the Kolmogorov-Smirnov test (p>0.05) and ANCOVA being robust 
in normality violations. Homoscedasticity and homogeneity of variances were 
also confirmed by visual inspection of a scatterplot and Levene's test (p>0.05), 
respectively. No data outliers were found based on standardized residuals ≥ ±3 
SD’s. 
 523 
The linearity assumptions were violated for the rest of the AHEI components, 
even after variable transformation. Therefore, ANCOVAs were not run for the 
remaining of the components. 
Dietary data at 24-weeks 
An ANCOVA was run to determine the intervention effect on the AHEI score 
at 24-weeks. Visual inspection of a scatterplot confirmed that the linear 
relationship between 24-week AHEI scores and each of BMI, age, and baseline 
AHEI scores for each arm. The interaction terms were not statistically 
significant (all p>0.05) indicating homogeneity of regression slopes. Shapiro-
Wilk’s test indicated that standardised residuals at each arm were normally 
distributed (p>0.05). Homoscedasticity and homogeneity of variances were also 
confirmed by visual inspection of a scatterplot and Levene's test (p>0.05), 
respectively. No data outliers were found based on standardized residuals ≥ ±3 
SD’s. 
An ANCOVA was run to determine the intervention effect on the vegetable 
score at 24-weeks. Visual inspection of a scatterplot confirmed that the linear 
relationship between 24-week vegetable scores and each of BMI, age, and 
baseline vegetable scores for each arm. The interaction terms were not 
statistically significant (all p>0.05) indicating homogeneity of regression slopes. 
Shapiro-Wilk’s test indicated that standardised residuals at each arm were 
normally distributed (p>0.05). Homoscedasticity and homogeneity of variances 
were also confirmed by visual inspection of a scatterplot and Levene's test 
(p>0.05), respectively. No data outliers were found based on standardized 
residuals ≥ ±3 SD’s. 
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Physical activity data at 8-weeks 
An ANCOVA was run to determine the intervention effect on the total energy 
expenditure at 8-weeks. Visual inspection of a scatterplot confirmed that the 
linear relationship between 8-week total energy expenditure and each of baseline 
energy expenditure and BMI for each arm. The linearity assumption was not met 
between energy expenditure and age despite extensive transformations, and, 
thus, age was not included in the model. The interaction terms were not 
statistically significant (all p>0.05) indicating homogeneity of regression slopes. 
Kolmogorov-Smirnov’s test indicated that standardised residuals at each arm 
were normally distributed (p>0.05). Homoscedasticity and homogeneity of 
variances were also confirmed by visual inspection of a scatterplot and Levene's 
test (p>0.05), respectively. There was one outlier (+3.6SDs) based on 
standardized residuals ≥ ±3 SD’s. As this was a genuinely unusual value of high 
energy expenditure, it was kept in the analysis. A sensitivity analysis excluding 
the outlier was run, but the results did not differ substantially.  
Physical activity data at 24-weeks 
An ANCOVA was run to determine the intervention effect on the total energy 
expenditure at 24-weeks. Visual inspection of a scatterplot confirmed that the 
linear relationship between 8-week total energy expenditure and each of baseline 
energy expenditure, age, and log-BMI for each arm. The interaction terms were 
not statistically significant (all p>0.05) indicating homogeneity of regression 
slopes. Shapiro-Wilk’s test indicated that standardised residuals at each arm were 
normally distributed (p>0.05). Homoscedasticity and homogeneity of variances 
were also confirmed by visual inspection of a scatterplot and Levene's test 
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(p>0.05), respectively. No data outliers were found based on standardized 
residuals ≥ ±3 SD’s. 
Anthropometry data at 8-weeks 
An ANCOVA was run to determine the intervention effect on weight at 8-
weeks. Visual inspection of a scatterplot confirmed that the linear relationship 
between 8-week weight and each of baseline weight, and age for each arm. The 
interaction terms were not statistically significant (all p>0.05) indicating 
homogeneity of regression slopes. Kolmogorov-Smirnov’s test indicated that 
standardised residuals were normally distributed in both arms (p>0.05). 
Homoscedasticity and homogeneity of variances were also confirmed by visual 
inspection of a scatterplot and Levene's test (p>0.05), respectively. There was 
one outlier (-3.3SDs) based on standardized residuals ≥ ±3 SD’s that was 
maintained in the analysis as a genuinely unusual value. A sensitivity analysis 
excluding the outlier was run, but the results did not differ substantially. 
An ANCOVA was run to determine the intervention effect on BMI at 8-weeks. 
Visual inspection of a scatterplot confirmed that the linear relationship between 
8-week BMI and each of baseline BMI, and age for each arm. The interaction 
terms were not statistically significant (all p>0.05) indicating homogeneity of 
regression slopes. Kolmogorov-Smirnov’s test indicated that standardised 
residuals were normally distributed in both arms (p>0.05). Homoscedasticity 
and homogeneity of variances were also confirmed by visual inspection of a 
scatterplot and Levene's test (p>0.05), respectively. There was one outlier (-
3.31Ds) based on standardized residuals ≥ ±3 SD’s that was maintained in the 
analysis as a genuinely unusual value. A sensitivity analysis excluding the outlier 
was run, but the results did not differ substantially. 
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An ANCOVA was run to determine the intervention effect on fat mass at 8-
weeks. Visual inspection of a scatterplot confirmed that the linear relationship 
between 8-week fat mass and each of baseline fat mass, and age for each arm 
(BMI was not included in the model). The interaction terms were not statistically 
significant (all p>0.05) indicating homogeneity of regression slopes. Shapiro-
Wilk’s test indicated that standardised residuals were normally distributed only 
in the control arm (p>0.05). The analysis was performed as ANCOVA is robust 
in such violations. Homoscedasticity and homogeneity of variances were also 
confirmed by visual inspection of a scatterplot and Levene's test (p>0.05), 
respectively. There was one outlier (+3.9 SD’s) based on standardized residuals 
≥ ±3 SD’s that was maintained in the analysis as a genuinely unusual value. A 
sensitivity analysis excluding the outlier was run, but the results did not differ 
substantially. 
An ANCOVA was run to determine the intervention effect on muscle mass at 
8-weeks. Visual inspection of a scatterplot confirmed that the linear relationship 
between 8-week muscle mass and each of baseline muscle mass, and age for each 
arm (BMI was not included in the model). The interaction terms were not 
statistically significant (all p>0.05) indicating homogeneity of regression slopes. 
Kolmogorov-Smirnov’s test indicated that standardised residuals were normally 
distributed in both arms (p>0.05). Homoscedasticity and homogeneity of 
variances were also confirmed by visual inspection of a scatterplot and Levene's 
test (p>0.05), respectively. No data outliers were found based on standardized 
residuals ≥ ±3 SD’s. 
An ANCOVA was run to determine the intervention effect on FMI at 8-weeks. 
Visual inspection of a scatterplot confirmed that the linear relationship between 
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8-week FMI and each of baseline FMI, and age for each arm (BMI was not 
included in the model). The interaction terms were not statistically significant 
(all p>0.05) indicating homogeneity of regression slopes. Shapiro-Wilk’s test 
indicated that standardised residuals were normally distributed only on the 
control arm (p>0.05). The analysis was performed given the robustness of 
ANCOVA to such violation. Homoscedasticity and homogeneity of variances 
were also confirmed by visual inspection of a scatterplot and Levene's test 
(p>0.05), respectively. No data outliers were found based on standardized 
residuals ≥ ±3 SD’s. 
An ANCOVA was run to determine the intervention effect on FFMI at 8-weeks. 
Visual inspection of a scatterplot confirmed that the linear relationship between 
8-week FFMI and baseline FFMI for each arm (Age and BMI were not included 
in the model; age did not show linearity). The interaction terms were not 
statistically significant (all p>0.05) indicating homogeneity of regression slopes. 
Shapiro-Wilk’s test indicated that standardised residuals were normally 
distributed (p>0.05). Homoscedasticity and homogeneity of variances were also 
confirmed by visual inspection of a scatterplot and Levene's test (p>0.05), 
respectively. No data outliers were found based on standardized residuals ≥ ±3 
SD’s. 
An ANCOVA was run to determine the intervention effect on systolic blood 
pressure at 8-weeks. Visual inspection of a scatterplot confirmed that the linear 
relationship between 8-week systolic blood pressure and baseline systolic blood 
pressure, age, and BMI for each arm. The interaction terms were not statistically 
significant (all p>0.05) indicating homogeneity of regression slopes. Shapiro-
Wilk’s test indicated that standardised residuals were normally distributed in 
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both arms (p>0.05). Homoscedasticity and homogeneity of variances were also 
confirmed by visual inspection of a scatterplot and Levene's test (p>0.05), 
respectively. There was one outlier (+3.1 SD’s) based on standardized residuals 
≥ ±3 SD’s that was maintained in the analysis as a genuinely unusual value. 
An ANCOVA was run to determine the intervention effect on diastolic blood 
pressure at 8-weeks. Visual inspection of a scatterplot confirmed that the linear 
relationship between 8-week diastolic blood pressure and baseline systolic blood 
pressure, age, and BMI for each arm. The interaction terms were not statistically 
significant (all p>0.05) indicating homogeneity of regression slopes. The 
assumption of homogeneity of variances was not met based on Levene's test 
(p<0.05). Thus, the ANCOVA was not reported. 
An ANCOVA was run to determine the intervention effect on handgrip strength 
at 8-weeks. Visual inspection of a scatterplot confirmed that the linear 
relationship between 8-week handgrip strength and baseline handgrip strength, 
and age for each arm. BMI was not included in the model because the linearity 
assumption was not met. The interaction terms were not statistically significant 
(all p>0.05) indicating homogeneity of regression slopes. Shapiro-Wilk’s test 
indicated that standardised residuals were normally distributed in both arms 
(p>0.05). Homoscedasticity and homogeneity of variances were also confirmed 
by visual inspection of a scatterplot and Levene's test (p>0.05), respectively. No 
data outliers were found based on standardized residuals ≥ ±3 SD’s.  
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Anthropometry data at 24-weeks 
An ANCOVA was run to determine the intervention effect on weight at 24-
weeks. Visual inspection of a scatterplot confirmed that the linear relationship 
between 24-week weight and each of baseline weight, and age for each arm. The 
interaction terms were not statistically significant (all p>0.05) indicating 
homogeneity of regression slopes. Shapiro-Wilk’s test indicated that 
standardised residuals were normally distributed only on the active intervention 
arm (p>0.05). The analysis was performed given the robustness of ANCOVA 
to such violation. Homoscedasticity and homogeneity of variances were also 
confirmed by visual inspection of a scatterplot and Levene's test (p>0.05), 
respectively. No data outliers were found based on standardized residuals ≥ ±3 
SD’s. 
An ANCOVA was run to determine the intervention effect on BMI at 24-weeks. 
Visual inspection of a scatterplot confirmed that the linear relationship between 
24-week BMI and each of baseline BMI, and age for each arm. The interaction 
terms were not statistically significant (all p>0.05) indicating homogeneity of 
regression slopes. Shapiro-Wilk’s test indicated that standardised residuals were 
normally distributed only in the active arm (p>0.05). The analysis was performed 
as ANCOVA is robust to such violation. Homoscedasticity and homogeneity of 
variances were also confirmed by visual inspection of a scatterplot and Levene's 
test (p=0.50), respectively. No data outliers were found based on standardized 
residuals ≥ ±3 SD’s. 
An ANCOVA was run to determine the intervention effect on fat mass at 24-
weeks. Visual inspection of a scatterplot confirmed that the linear relationship 
between 8-week fat mass and each of baseline fat mass, and age for each arm. 
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The interaction terms were not statistically significant (all p>0.05) indicating 
homogeneity of regression slopes. Shapiro-Wilk’s test indicated that 
standardised residuals were normally distributed only in the active arm (p>0.05). 
The analysis was performed as ANCOVA is robust in such violations. 
Homoscedasticity and homogeneity of variances were also confirmed by visual 
inspection of a scatterplot and Levene's test (p>0.05), respectively. No data 
outliers were found based on standardized residuals ≥ ±3 SD’s. 
An ANCOVA was run to determine the intervention effect on muscle mass at 
24-weeks. Visual inspection of a scatterplot confirmed that the linear 
relationship between 8-week muscle mass and each of baseline muscle mass, and 
age for each arm. The interaction terms were not statistically significant (all 
p>0.05) indicating homogeneity of regression slopes. Shapiro-Wilk’s test 
indicated that standardised residuals were normally distributed only in both arm 
(p>0.05). Homoscedasticity and homogeneity of variances were also confirmed 
by visual inspection of a scatterplot and Levene's test (p>0.05), respectively. No 
data outliers were found based on standardized residuals ≥ ±3 SD’s. 
An ANCOVA was run to determine the intervention effect on FMI at 24-weeks. 
Visual inspection of a scatterplot confirmed that the linear relationship between 
24-week FMI and each of baseline FMI, and age for each arm (BMI was not 
included in the model). The interaction terms were not statistically significant 
(all p>0.05) indicating homogeneity of regression slopes. Shapiro-Wilk’s test 
indicated that standardised residuals were normally distributed only on the active 
arm (p>0.05). The analysis was performed given the robustness of ANCOVA 
to such violation. Homoscedasticity and homogeneity of variances were also 
confirmed by visual inspection of a scatterplot and Levene's test (p>0.05), 
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respectively. No data outliers were found based on standardized residuals ≥ ±3 
SD’s. 
An ANCOVA was run to determine the intervention effect on FFMI at 24-
weeks. Visual inspection of a scatterplot confirmed that the linear relationship 
between 24-week FFMI and baseline FFMI for each arm (Age and BMI were 
not included in the model; age did not show linearity). The interaction terms 
were not statistically significant (all p>0.05) indicating homogeneity of 
regression slopes. Shapiro-Wilk’s test indicated that standardised residuals were 
normally distributed (p>0.05). Homoscedasticity and homogeneity of variances 
were also confirmed by visual inspection of a scatterplot and Levene's test 
(p>0.05), respectively. No data outliers were found based on standardized 
residuals ≥ ±3 SD’s. 
An ANCOVA was run to determine the intervention effect on systolic blood 
pressure at 24-weeks. Visual inspection of a scatterplot confirmed that the linear 
relationship between 24-week systolic blood pressure and baseline systolic blood 
pressure, age, and BMI for each arm. The interaction terms were not statistically 
significant (all p>0.05) indicating homogeneity of regression slopes. Shapiro-
Wilk’s test indicated that standardised residuals were normally distributed only 
in the control arm (p>0.05). The analysis was performed given the robustness 
of ANCOVA to such violation. Homoscedasticity and homogeneity of variances 
were also confirmed by visual inspection of a scatterplot and Levene's test 
(p>0.05), respectively. There was one outlier (+3.5 SD’s) based on standardized 
residuals ≥ ±3 SD’s that was maintained in the analysis as a genuinely unusual 
value. 
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An ANCOVA was run to determine the intervention effect on diastolic blood 
pressure at 24-weeks. Visual inspection of a scatterplot confirmed that the linear 
relationship between 24-week diastolic blood pressure and baseline diastolic 
blood pressure, age, and BMI for each arm. The interaction terms were not 
statistically significant (all p>0.05) indicating homogeneity of regression slopes. 
Kolmogorov-Smirnov’s test indicated that standardised residuals were normally 
distributed in both arms (p>0.05). Homoscedasticity and homogeneity of 
variances were also confirmed by visual inspection of a scatterplot and Levene's 
test (p>0.05), respectively. No data outliers were found based on standardized 
residuals ≥ ±3 SD’s. 
An ANCOVA was run to determine the intervention effect on handgrip strength 
at 24-weeks. Visual inspection of a scatterplot confirmed that the linear 
relationship between 24-week handgrip strength and baseline handgrip strength, 
and age for each arm. BMI was not included in the model because the linearity 
assumption was not met. The interaction terms were not statistically significant 
(all p>0.05) indicating homogeneity of regression slopes. Shapiro-Wilk’s test 
indicated that standardised residuals were normally distributed in both arms 
(p>0.05). Homoscedasticity and homogeneity of variances were also confirmed 
by visual inspection of a scatterplot and Levene's test (p>0.05), respectively. No 
data outliers were found based on standardized residuals ≥ ±3 SD’s. 
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HRQoL data at 8-weeks 
An ANCOVA was run to determine the intervention effect on the global quality 
of life score at 8-weeks. Visual inspection of a scatterplot confirmed that the 
linear relationship between 8-week global QoL and each of baseline global QoL, 
age, and BMI for each arm. The interaction terms were not statistically 
significant (all p>0.05) indicating homogeneity of regression slopes. Shapiro-
Wilk’s test indicated that standardised residuals were normally distributed only 
on the active intervention arm (p>0.05). Although the residuals in the control 
arm were not normally distributed (p<0.001), there was no further action given 
the fair robustness of the ANCOVA model in such violation. Homoscedasticity 
and homogeneity of variances were also confirmed by visual inspection of a 
scatterplot and Levene's test (p=0.61), respectively. There was one outlier 
(+3.2SDs) based on standardized residuals ≥ ±3 SD’s that was maintained in 
the analysis as a genuinely unusual value. A sensitivity analysis excluding the 
outlier was run, but the results did not differ substantially. 
An ANCOVA was run to determine the intervention effect on the overall health 
score at 8-weeks. Visual inspection of a scatterplot confirmed that the linear 
relationship between 24-week overall health score and each of BMI, age, and 
baseline overall health score for each arm. The interaction terms were not 
statistically significant (all p>0.05) indicating homogeneity of regression slopes. 
Shapiro-Wilk’s test indicated that standardised residuals at each arm were 
normally distributed (p>0.05). Homoscedasticity and homogeneity of variances 
were also confirmed by visual inspection of a scatterplot and Levene's test 
(p>0.05), respectively. There was one outlier (+3.4SDs) based on standardized 
residuals ≥ ±3 SD’s that was maintained in the analysis as a genuinely unusual 
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value. A sensitivity analysis excluding the outlier was run, but the results did not 
differ substantially. 
An ANCOVA was run to determine the intervention effect on the physical 
functioning score at 8-weeks. Visual inspection of a scatterplot confirmed that 
the linear relationship between 8-week physical functioning score and each of 
age, and baseline physical functioning score for each arm. The linearity 
assumption was not met for BMI even after multiple transformations; thus BMI 
was not included in the model. The interaction terms were not statistically 
significant (all p>0.05) indicating homogeneity of regression slopes. Shapiro-
Wilk’s test indicated that standardised residuals at each arm were not normally 
distributed (p>0.05). The analysis was performed given the robustness of 
ANCOVA to such violation. Homoscedasticity and homogeneity of variances 
were also confirmed by visual inspection of a scatterplot and Levene's test 
(p>0.05), respectively. No data outliers were found based on standardized 
residuals ≥ ±3 SD’s. 
No ANCOVA was run for role, emotional, and social emotional functioning 
scores, and pain, nausea, appetite loss, constipation, diarrhoea, and financial 
difficulties at 8-weeks because the linearity assumption with the covariates was 
not met, even after multiple transformations. An ANCOVA was run for 
cognitive functioning score at 8-weeks. There was no homogeneity of regression 
slopes for the baseline cognitive score (interaction term p=0.012). When the 
model was run omitting the baseline cognitive score, there was no homogeneity 
of variances (Levene’s test p<0.05). Thus, ANCOVA analysis was not reported. 
There  
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An ANCOVA was run to determine the intervention effect on the fatigue score 
at 8-weeks. Visual inspection of a scatterplot confirmed that the approximate 
linear relationship between 8-week fatigue score and each of BMI, age, and 
baseline fatigue score for each arm. The interaction terms were not statistically 
significant (all p>0.05) indicating homogeneity of regression slopes. 
Kolmogorov-Smirnov’s test indicated that standardised residuals at each arm 
were normally distributed (p>0.05). Homoscedasticity and homogeneity of 
variances were also confirmed by visual inspection of a scatterplot and Levene's 
test (p>0.05), respectively. No data outliers were found based on standardized 
residuals ≥ ±3 SD’s. 
An ANCOVA was run to determine the intervention effect on the insomnia 
score at 8-weeks. Visual inspection of a scatterplot confirmed that the linear 
relationship between 8-week insomnia score and each of BMI, age, and baseline 
insomnia score for each arm. The interaction terms were not statistically 
significant (all p>0.05) indicating homogeneity of regression slopes. Shapiro-
Wilk’s test indicated that standardised residuals at each arm were normally 
distributed (p>0.05). Homoscedasticity and homogeneity of variances were also 
confirmed by visual inspection of a scatterplot and Levene's test (p>0.05), 
respectively. No data outliers were found based on standardized residuals ≥ ±3 
SD’s. 
HRQoL data at 24-weeks 
An ANCOVA was run to determine the intervention effect on the global quality 
of life score at 24-weeks. Visual inspection of a scatterplot confirmed that the 
linear relationship between 24-week AHEI scores and each of BMI,, and 
baseline global quality of life score for each arm. The linearity assumption for 
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age was not met even after multiple transformations, and, thus, age was not 
included in the adjusted model. The interaction terms were not statistically 
significant (all p>0.05) indicating homogeneity of regression slopes. Shapiro-
Wilk’s test indicated that standardised residuals at each arm were normally 
distributed (p>0.05). Homoscedasticity and homogeneity of variances were also 
confirmed by visual inspection of a scatterplot and Levene's test (p>0.05), 
respectively. No data outliers were found based on standardized residuals ≥ ±3 
SD’s. 
An ANCOVA was run to determine the intervention effect on the overall health 
score at 24-weeks. Visual inspection of a scatterplot confirmed that the linear 
relationship between 24-week overall health score and baseline overall health 
score for each arm. The linearity assumption was not met for BMI or age even 
after multiple transformations; thus these were not included as covariates. The 
interaction terms were not statistically significant (p>0.05) indicating 
homogeneity of regression slopes. Shapiro-Wilk’s test indicated that 
standardised residuals at each arm were not normally distributed (p>0.05). The 
analysis was performed given the robustness of ANCOVA to such violation. 
Homoscedasticity and homogeneity of variances were also confirmed by visual 
inspection of a scatterplot and Levene's test (p=0.72), respectively. No data 
outliers were found based on standardized residuals ≥ ±3 SD’s. There was one 
outlier (-4.1SDs) based on standardized residuals ≥ ±3 SD’s that was maintained 
in the analysis as a genuinely unusual value. A sensitivity analysis excluding the 
outlier was run, but the results did not differ substantially. 
An ANCOVA was run to determine the intervention effect on the physical 
functioning score at 24-weeks. Visual inspection of a scatterplot confirmed that 
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the linear relationship between 24-week physical functioning score and each of 
BMI, age, and baseline physical functioning score for each arm. The interaction 
terms were not statistically significant (all p>0.05) indicating homogeneity of 
regression slopes. Shapiro-Wilk’s test indicated that standardised residuals at 
each arm were normally distributed (p>0.05). Homoscedasticity and 
homogeneity of variances were also confirmed by visual inspection of a 
scatterplot and Levene's test (p>0.05), respectively. No data outliers were found 
based on standardized residuals ≥ ±3 SD’s. 
No ANCOVA was run for role, cognitive, and social functioning scores, pain, 
nausea, dyspnoea, appetite loss, constipation, diarrhoea, and financial difficulties 
at 24-weeks as the linearity assumptions with the covariates were not met. An 
ANCOVA was run for emotional functioning score at 24-weeks with baseline 
emotional functioning score and BMI as covariates. There was no homogeneity 
of regression slopes for the baseline score (interaction term p=0.002). Thus, 
ANCOVA analysis was not undertaken.  
An ANCOVA was run to determine the intervention effect on the fatigue score 
at 24-weeks. Visual inspection of a scatterplot confirmed that the linear 
relationship between 24-week fatigue score and each of BMI, age, and baseline 
fatigue score for each arm. The interaction terms were not statistically significant 
(all p>0.05) indicating homogeneity of regression slopes. Shapiro-Wilk’s test 
indicated that standardised residuals at each arm were normally distributed 
(p>0.05). Homoscedasticity and homogeneity of variances were also confirmed 
by visual inspection of a scatterplot and Levene's test (p>0.05), respectively. No 
data outliers were found based on standardized residuals ≥ ±3 SD’s. 
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An ANCOVA was run to determine the intervention effect on the insomnia 
score at 24-weeks. Visual inspection of a scatterplot confirmed that the linear 
relationship between 24-week insomnia score and each of BMI, age, and baseline 
insomnia score for each arm. The interaction terms were not statistically 
significant (all p>0.05) indicating homogeneity of regression slopes. Shapiro-
Wilk’s test indicated that standardised residuals at each arm were normally 
distributed (p>0.05). Homoscedasticity and homogeneity of variances were also 
confirmed by visual inspection of a scatterplot and Levene's test (p>0.05), 
respectively. No data outliers were found based on standardized residuals ≥ ±3 
SD’s. 
Health state at 8-weeks and 24-weeks 
An ANCOVA was run to determine the intervention effect on the EQ-5D 
health state visual analogue scale at 8-weeks. Visual inspection of a scatterplot 
confirmed that the linear relationship between 8-week health state score and 
each of BMI, age, and baseline health state score for each arm. The interaction 
terms were not statistically significant (all p>0.05) indicating homogeneity of 
regression slopes. Shapiro-Wilk’s test indicated that standardised residuals at 
each arm were normally distributed (p>0.05). Homoscedasticity and 
homogeneity of variances were also confirmed by visual inspection of a 
scatterplot and Levene's test (p>0.05), respectively. No data outliers were found 
based on standardized residuals ≥ ±3 SD’s. 
An ANCOVA was run to determine the intervention effect on the EQ-5D 
health state visual analogue scale at 24-weeks. Visual inspection of a scatterplot 
confirmed that the linear relationship between 24-week health state score and 
each of BMI, age, and baseline health state score for each arm. The interaction 
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terms were not statistically significant (all p>0.05) indicating homogeneity of 
regression slopes. Shapiro-Wilk’s test indicated that standardised residuals at 
each arm were normally distributed (p>0.05). Homoscedasticity and 
homogeneity of variances were also confirmed by visual inspection of a 
scatterplot and Levene's test (p>0.05), respectively. No data outliers were found 
based on standardized residuals ≥ ±3 SD’s. 
Shape-Up self efficacy score at 8-weeks and 24-weeks 
An ANCOVA was run to determine the intervention effect on the total self-
efficacy score at 8-weeks. Visual inspection of a scatterplot confirmed that the 
linear relationship between 8-week self-efficacy score score and each of age, and 
baseline self-efficacy score for each arm. BMI was not included in the model 
because the linearity assumption was not met. The interaction terms were not 
statistically significant (all p>0.05) indicating homogeneity of regression slopes. 
Shapiro-Wilk’s test indicated that standardised residuals at each arm were not 
normally distributed (p<0.05). However, the analysis was performed as 
ANCOVA is somewhat robust to such violations. Homoscedasticity and 
homogeneity of variances were also confirmed by visual inspection of a 
scatterplot and Levene's test (p>0.05), respectively. There was one outlier (+4.3 
SDs) based on standardized residuals ≥ ±3 SD’s that was maintained in the 
analysis as a genuinely unusual value. A sensitivity analysis excluding the outlier 
was run, but the results did not differ substantially. 
No ANCOVA was run for the self-efficacy score at 24-weeks as the linearity 
assumptions were not met. 
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Multiple imputation  
A fully conditional specification model with 20 iterations produced 10 
imputations cycles (total n=54). Constraints were applied to all variables based 
on minimum and maximum observed scores. The model was satisfactory as data 
were converged (example of AHEI score in figure below).  
The results of the multiple imputation trended towards the same direction as 
those from the complete-case analysis adding to the validity of the estimates.  
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 Mean (SD) Active intervention minus usual care 
                 
Adjusted Mean 
Group Difference at 
8w (SE) (P-value) 
Adjusted Mean 
Group Difference at 
24w (SE) (P-value) Scores 
Shape-Up FCT (n=26) Care as usual (n=28) 
          
 
          
 
Baseline 8weeks 24weeks Baseline 8weeks 24weeks 
AHEI-2010  58.7 (12.3) 63.2 (14.7) 61.6 (15.9) 59.3 (15.2) 56.7 (15.8) 60.0 (18.7) 7.0 (4.4) (0.109) 1.0 (4.6) (0.831) 
EE (MET-h) 35.1 (2.0) 33.9 (2.5) 35.5 (3.1) 35.8 (2.7) 34.6 (4.6) 36.2 (3.3) -0.2 (1.1) (0.880) -0.05 (0.8) (0.061) 
Weight 69.8 (14.3) 69.0 (14.5) 68.8 (13.5) 72.4 (14.0) 72.0 (14.3) 71.6 (14.0) -0.4 (0.8) (0.585) -0.2 (0.9) (0.814) 
BMI 27.3 (6.3) 26.9 (6.4) 26.9 (6.1) 28.7 (5.6) 28.5 (5.8) 28.3 (5.7) -0.1 (0.3) (0.668) -0.1 (0.4) (0.753) 
Fat mass (kg) 25.5 (9.7) 25.2 (9.7) 24.5 (9.1) 27.8 (9.4) 27.2 (9.3) 26.8 (9.2) 0.2 (0.9) (0.872) -0.2 (0.8) (0.853) 
Muscle mass (kg) 42.0 (5.2) 41.5 (5.4) 42.1 (5.2) 42.4 (5.1) 42.5 (5.8) 42.5 (5.5) -0.7 (0.6) (0.296) -0.1 (0.5) (0.809) 
Global QoL 71.2 (18.8) 72.9 (18.1) 80.1 (17.9) 73.2 (21.1) 69.9 (22.2) 74.3 (19.3) 3.9 (5.4) (0.476) 6.4 (5.1) (0.207) 
Overall health 66.0 (17.0) 71.9 (20.3) 77.7 (21.6) 70.8 (18.7) 66.9 (25.5) 66.1 (24.6) 7.5 (6.4) (0.240) 15.2 (6.5) (0.021) 
Physical functioning 89.5 (11.6) 91.2 (12.2) 90.6 (12.3) 90.7 (14.5) 85.8 (17.8) 89.5 (15.0) 6.0 (3.5) (0.086) 2.0 (2.9) (0.496) 
Role functioning 87.8 (15.0) 86.4 (18.5) 90.4 (16.4) 92.9 (13.0) 82.0 (28.2) 82.4 (25.0) 4.7 (7.1) (0.506) 9.1 (6.1) (0.138) 
Fatigue 21.4 (15.7) 19.6 (18.3) 16.6 (16.4) 21.3 (18.8) 27.8 (24.9) 22.9 (19.2) -6.4 (5.5) (0.246) -5.6 (5.0) (0.259) 
Pain 21.2 (26.0) 17.0 (20.6) 15.7 (20.3) 12.5 (16.5) 19.9 (25.3) 21.9 (28.2) -8.4 (5.6) (0.147) -9.7 (6.7) (0.148) 
EE: Energy expenditure, MET: Metabolic equivalents, FCT: following cancer treatment. Observed means (SD) are presented.  
Models adjusted for age, BMI, and baseline values. 
Optimal potential AHEI-2010 score=110. Optimal potential score for each AHEI-2010 dietary component=10.  
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Appendix 16 Published trial protocol in Trials 
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Appendix 17 CONSORT checklist 
Section/Topic 
Item 
No Checklist item 
Reported 
on section 
Title and abstract 
 1a Identification as a randomised trial in the title n/a 
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see 
CONSORT for abstracts) 
n/a 
Introduction 
Background and 
objectives 
2a Scientific background and explanation of rationale Chapter 7 
2b Specific objectives or hypotheses 8.3 
Methods 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio 8.4 
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons 8.5.7.3.1 
Participants 4a Eligibility criteria for participants 8.5.2 
4b Settings and locations where the data were collected 8.5.1 
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when 
they were actually administered 
8.5.3 
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and when 
they were assessed 
8.5.4, 8.5.7 
6b Any changes to trial outcomes after the trial commenced, with reasons 8.5.7.3.1 
Sample size 7a How sample size was determined 8.5.8 
7b When applicable, explanation of any interim analyses and stopping guidelines n/a 
Randomisation:    
 Sequence 
generation 
8a Method used to generate the random allocation sequence 8.5.6 
8b Type of randomisation; details of any restriction (such as blocking and block size) 8.5.6 
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Section/Topic 
Item 
No Checklist item 
Reported 
on section 
 Allocation 
concealment 
mechanism 
9 Mechanism used to implement the random allocation sequence (such as sequentially numbered 
containers), describing any steps taken to conceal the sequence until interventions were assigned 
8.5.6.2 
 Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned 
participants to interventions 
8.5.6.3 
Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, 
those assessing outcomes) and how 
8.5.6.4 
11b If relevant, description of the similarity of interventions n/a 
Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes 8.5.8 
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses 8.5.8 
Results 
Participant flow (a 
diagram is strongly 
recommended) 
13a For each group, the numbers of participants who were randomly assigned, received intended treatment, 
and were analysed for the primary outcome 
Figure 8.3 
13b For each group, losses and exclusions after randomisation, together with reasons Figure 8.3, 
8.6.1 
Recruitment 14a Dates defining the periods of recruitment and follow-up 8.6.1 
14b Why the trial ended or was stopped n/a 
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group Table 8.4 
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the 
analysis was by original assigned groups 
Tables 8.6 – 
8.12 
Outcomes and 
estimation 
17a For each primary and secondary outcome, results for each group, and the estimated effect size and its 
precision (such as 95% confidence interval) 
Tables 8.6 – 
8.12 
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended n/a 
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, 
distinguishing pre-specified from exploratory 
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Section/Topic 
Item 
No Checklist item 
Reported 
on section 
Harms 19 All important harms or unintended effects in each group (for specific guidance see CONSORT for 
harms) 
8.6.9 
Discussion 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of 
analyses 
8.7 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings 8.7 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant 
evidence 
8.7 
Other information  
Registration 23 Registration number and name of trial registry 8.4 
Protocol 24 Where the full trial protocol can be accessed, if available Appendix 16 
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders Appendix 14 
 
 
